Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Oral Oncol

Retrieve available abstracts of 787 articles:
HTML format



Single Articles


    August 2022
  1. LU HJ, Peng CY, Tseng HC, Hsin CH, et al
    Preoperative prediction model to evaluate salvage surgery in patients with recurrent or second primary oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;131:105951.
    PubMed     Abstract available


  2. ZANOLETTI E, Tealdo G, Franz L, Cazzador D, et al
    From "Extended total parotidectomy" to "Temporo-parotid resection" for locally advanced parotid tumors: Outlining a shift in surgical perspective.
    Oral Oncol. 2022;131:105975.
    PubMed    


  3. STANBOULY D, Philipone E, Morlandt AB, Kaleem A, et al
    Adverse events secondary to cetuximab therapy in head & neck cancer therapy and risk factors for serious outcomes.
    Oral Oncol. 2022;131:105952.
    PubMed     Abstract available


  4. SIVAPERUMAL P, Sekaran S, Kamala K, Ganapathy D, et al
    Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;131:105971.
    PubMed    


  5. WU Y, Koyuncu CF, Toro P, Corredor G, et al
    A machine learning model for separating epithelial and stromal regions in oral cavity squamous cell carcinomas using H&E-stained histology images: A multi-center, retrospective study.
    Oral Oncol. 2022;131:105942.
    PubMed     Abstract available


  6. HAN N, Li X, Wang Y, Li H, et al
    HIF-1alpha induced NID1 expression promotes pulmonary metastases via the PI3K-AKT pathway in salivary gland adenoid cystic carcinoma.
    Oral Oncol. 2022;131:105940.
    PubMed     Abstract available


  7. DONA MG, Rollo F, Pichi B, Moretto S, et al
    Updates on Human Papillomavirus-driven oropharyngeal squamous cell carcinomas in a southern European country.
    Oral Oncol. 2022;131:105947.
    PubMed    


    July 2022
  8. DE VRIES J, Poelman A, Sidorenkov G, Festen S, et al
    The association of frailty and outcomes of geriatric assessment with acute radiation-induced toxicity in patients with head and neck cancer.
    Oral Oncol. 2022;130:105933.
    PubMed     Abstract available


  9. RIBEIRO MFA, Oliveira MCM, Leite AC, Bruzinga FFB, et al
    Assessment of screening programs as a strategy for early detection of oral cancer: a systematic review.
    Oral Oncol. 2022;130:105936.
    PubMed     Abstract available


  10. KAZEMIAN E, Solinski M, Adams W, Moore M, et al
    The role of perineural invasion in parotid malignancy outcomes: A systematic review and meta-analysis.
    Oral Oncol. 2022;130:105937.
    PubMed     Abstract available


  11. JAYARAMAN S, Sekar R, Veeraraghavan VP, Raj AT, et al
    MALAT 1 a modulator of PD-1/PD-L1 regulation in oral malignancies: An emerging target in cancer therapy.
    Oral Oncol. 2022;130:105950.
    PubMed    


  12. FANG Y, Peng Z, Wang Y, Gao K, et al
    Current opinions on diagnosis and treatment of adenoid cystic carcinoma.
    Oral Oncol. 2022;130:105945.
    PubMed     Abstract available


  13. MIN Y, Feng Y, He D, Zeng X, et al
    Is Age >/= 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study.
    Oral Oncol. 2022;130:105938.
    PubMed     Abstract available


  14. LI C, Zhang Q, Sun K, Jia H, et al
    Autofluorescence imaging as a noninvasive tool of risk stratification for malignant transformation of oral leukoplakia: A follow-up cohort study.
    Oral Oncol. 2022;130:105941.
    PubMed     Abstract available


  15. PONNIAH I
    "In response to "Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia".
    Oral Oncol. 2022;130:105944.
    PubMed    


  16. MENDONCA P, Sunny SP, Mohan U, Birur N P, et al
    Non-invasive imaging of oral potentially malignant and malignant lesions: A systematic review and meta-analysis.
    Oral Oncol. 2022;130:105877.
    PubMed     Abstract available


  17. KIL WJ
    Rapid physical and emotional palliation from QUAD shot radiotherapy to a frail elderly patient with stage IV parotid gland cancer-associated facial paralysis and pain when no other palliative intervention was available during COVID-19 pandemic.
    Oral Oncol. 2022;130:105930.
    PubMed    


  18. SELVAKUMAR SC, K Auxzilia P, Dinesh Y, Senthilmurugan M, et al
    MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105925.
    PubMed    


  19. KIONG KL, Moreno A, Vu CN, Zheng G, et al
    Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.
    Oral Oncol. 2022;130:105906.
    PubMed     Abstract available


  20. MA P, Shen HY, Chen DS, Lu ZY, et al
    Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma.
    Oral Oncol. 2022;130:105905.
    PubMed    


  21. TANG R, Mao S, Liu S, Li Z, et al
    Types of endoscopic surgical approaches for benign parapharyngeal space tumors.
    Oral Oncol. 2022;130:105875.
    PubMed    


  22. DOLL C, Mrosk F, Wuester J, Runge AS, et al
    Pattern of cervical lymph node metastases in squamous cell carcinoma of the upper oral cavity - How to manage the neck.
    Oral Oncol. 2022;130:105898.
    PubMed     Abstract available


  23. MAZEROLLE P, Fuchsmann C, Schultz P, Benmoussa N, et al
    Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter study.
    Oral Oncol. 2022;130:105896.
    PubMed     Abstract available


  24. VIGARIOS E, Warnakulasuriya S, Piau A, Giraudeau N, et al
    Early detection of oral malignancies may involve the development of tele-expertise in dentistry.
    Oral Oncol. 2022;130:105904.
    PubMed    


  25. YANG X, Zhou T, Ji T, Jia H, et al
    Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105901.
    PubMed    


  26. JAYASEELAN VP, A S SG, Arumugam P
    Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105874.
    PubMed    


    June 2022
  27. MISRA SR, Das R
    Central oral medicine repository: A proposal to speed up the diagnostic process for oral potentially malignant disorders and oral carcinoma!
    Oral Oncol. 2022;132:105998.
    PubMed    


  28. BALACHANDER K, Paramasivam A
    Anti-PD-1 agent: A promising immunotherapy drug for oral cancer?
    Oral Oncol. 2022;132:105997.
    PubMed    


  29. BABU S, Krishnan M, Priya Veeraraghavan V, Jayaraman S, et al
    Role of salivary miRNAs in the diagnosis and prognosis of head and neck squamous cell carcinoma.
    Oral Oncol. 2022;132:105993.
    PubMed    


  30. ALESSANDRINI L, Ferrari M, Taboni S, Sbaraglia M, et al
    Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens.
    Oral Oncol. 2022;132:105982.
    PubMed     Abstract available


  31. SHREE HARINI K, Ezhilarasan D, Lakshmi T
    Novel fibroblast growth factor receptor inhibitors: Potential therapeutic approach in oral cancer treatment.
    Oral Oncol. 2022;132:105983.
    PubMed    


  32. REVATHI D, Dhanraj G, Ashok V
    Immune check point inhibitors: A promising therapeutic approach in oral cancer.
    Oral Oncol. 2022;132:105977.
    PubMed    


  33. SEKARAN S, Pitchaiah S, Ganapathy D
    Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?
    Oral Oncol. 2022;131:105973.
    PubMed    


  34. ZONG J, Ji P, Lin C, Zhang R, et al
    Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma.
    Oral Oncol. 2022;131:105972.
    PubMed     Abstract available


  35. BALACHANDER K, Paramasivam A
    Ferroptosis: An emerging therapeutic target for oral cancer.
    Oral Oncol. 2022;131:105970.
    PubMed    


  36. GANAPATHY D, Sekaran S, Pitchaiah S
    Is prognostic monitoring of high-risk populations at risk for oral cancer necessary after infection with COVID-19?
    Oral Oncol. 2022;131:105968.
    PubMed    


  37. LUO HD, Xia FJ, Wu JH, Yi B, et al
    Efficacy of chemoradiotherapy in survival of stage nasopharyngeal carcinoma and establishment of a prognostic model.
    Oral Oncol. 2022;131:105927.
    PubMed     Abstract available


  38. SHREE HARINI K, Ezhilarasan D, Lakshmi T
    Patient derived tumour organoids: An emerging strategy in oral cancer research and therapeutics.
    Oral Oncol. 2022;131:105954.
    PubMed    


  39. VARGHESE BT, Nair SP, Janardhan D
    Transglottic intralaryngeal papillary thyroid carcinoma.
    Oral Oncol. 2022;131:105935.
    PubMed     Abstract available


  40. YANG Z, Liao J, Schumaker L, Carter-Cooper B, et al
    Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.
    Oral Oncol. 2022;131:105939.
    PubMed     Abstract available


  41. SHREE HARINI K, Ezhilarasan D
    Promising autophagy inhibitors: Therapeutic implications in oral cancer.
    Oral Oncol. 2022;131:105948.
    PubMed    


  42. DE FELICE F
    FLASH radiotherapy in head and neck cancer: Myth or reality?
    Oral Oncol. 2022;131:105953.
    PubMed    


  43. VIJAYASHREE PRIYADHARSINI J, Anitha P
    Quantitative malignant index diagnosis system (qMIDS) for effective diagnosis of oral premalignant lesions.
    Oral Oncol. 2022;129:105902.
    PubMed    


  44. LEBOUCHER A, Sotton S, Gambin Flandrin I, Magne N, et al
    Head and neck radiotherapy-induced carotid toxicity: Pathophysiological concepts and clinical syndromes.
    Oral Oncol. 2022;129:105868.
    PubMed     Abstract available


  45. BALACHANDER K, Paramasivam A
    Mitophagy: A therapeutic target for oral squamous cell carcinoma.
    Oral Oncol. 2022;129:105881.
    PubMed    


  46. FERRELI F, Pirola F, Di Santo D, De Virgilio A, et al
    A critical analysis of the classifications of squamous cell carcinoma of the nasal vestibule.
    Oral Oncol. 2022;129:105880.
    PubMed    


  47. PAQUIN R, Gill B, Martin E, Byrd JK, et al
    Base of tongue neuroendocrine carcinoma: A case report.
    Oral Oncol. 2022;129:105780.
    PubMed     Abstract available


    May 2022
  48. JAYARAMAN S, Pazhani J, PriyaVeeraraghavan V, Raj AT, et al
    PCNA and Ki67: Prognostic proliferation markers for oral cancer.
    Oral Oncol. 2022;130:105943.
    PubMed    


  49. BALACHANDER K, Paramasivam A
    Selective autophagy as a potential therapeutic target for oral cancer.
    Oral Oncol. 2022;130:105934.
    PubMed    


  50. PATIL VM, Kolkur M, Kumar Chinthala S, Waratkar G, et al
    Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.
    Oral Oncol. 2022;130:105908.
    PubMed    


  51. UEDA Y, Okano S, Enokida T, Fujisawa T, et al
    Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
    Oral Oncol. 2022;130:105932.
    PubMed     Abstract available


  52. WARNER L, O'Hara JT, Lin DJ, Oozeer N, et al
    Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
    Oral Oncol. 2022;130:105909.
    PubMed     Abstract available


  53. VARGHESE BT, Shivanesan P
    Anatomical distortion of the right recurrent laryngeal nerve in level 7 neck dissection.
    Oral Oncol. 2022;130:105929.
    PubMed    


  54. SMILINE GIRIJA AS
    Natural "epidrugs" and the need of basket trials in the treatment of oral cancer in India.
    Oral Oncol. 2022;130:105931.
    PubMed    


  55. SHIAO JC, Holt D, Ladbury C, Gao D, et al
    The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;130:105907.
    PubMed     Abstract available


  56. LOW SK, Reed CT, Millo C, Turkbey EB, et al
    Cecal mass: An unusual site of metastasis from HPV-associated oropharyngeal cancer.
    Oral Oncol. 2022;130:105928.
    PubMed    


  57. PARAMASIVAM A
    Plasma circulating tumor DNA as a molecular marker for oral cancer.
    Oral Oncol. 2022;130:105926.
    PubMed    


  58. SELVARAJ J, Yasothkumar D, Vishnu Priya V, Raj AT, et al
    Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;130:105922.
    PubMed    


  59. YANG X, Song H, Ji T, Du G, et al
    The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
    Oral Oncol. 2022;130:105924.
    PubMed     Abstract available


  60. FORNER D, Mok F, Verma N, Karam I, et al
    Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients.
    Oral Oncol. 2022;130:105903.
    PubMed     Abstract available


  61. PAZHANI J, Jayaraman S, Veeraraghavan VP, Somasundaram DB, et al
    Targeting cancer associated fibroblasts - A TGF-beta based immunotherapy for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;130:105899.
    PubMed    


  62. JIANG Y, Yang S, Qi Y
    Comment on: The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
    Oral Oncol. 2022;130:105872.
    PubMed    


  63. MADY LJ, Baddour K, Hodges JC, Magana LC, et al
    Corrigendum to "The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm" [Oral Oncol. 126 (2022) 105766].
    Oral Oncol. 2022 May 2:105882. doi: 10.1016/j.oraloncology.2022.105882.
    PubMed    


  64. SWARTZ JE, Smits HJG, Philippens MEP, de Bree R, et al
    Correlation and colocalization of HIF-1alpha and pimonidazole staining for hypoxia in laryngeal squamous cell carcinomas: A digital, single-cell-based analysis.
    Oral Oncol. 2022;128:105862.
    PubMed     Abstract available


  65. YEOM S, Jung EK, Lee DH, Lee JK, et al
    Clinical features and recurrence factors of benign neoplasms of the tongue base.
    Oral Oncol. 2022;128:105866.
    PubMed     Abstract available


  66. COUTU B, Ryan E, Christensen D, Lawrence E, et al
    Positive margins matter regardless of subsequent resection findings.
    Oral Oncol. 2022;128:105850.
    PubMed     Abstract available


  67. MULLER RG, Hamill CS, Vu B, Thuener J, et al
    Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2022;128:105861.
    PubMed     Abstract available


  68. MOLNAR K, Hietanen S, Liisanantti J, Koivunen P, et al
    Quality of life after free flap reconstruction for the cancer of the head and neck: Comparison between five-year survivors and non-survivors.
    Oral Oncol. 2022;128:105855.
    PubMed     Abstract available


  69. TRANCHITO E, Cabrera C, Terry M, Li S, et al
    Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database.
    Oral Oncol. 2022;128:105829.
    PubMed     Abstract available


  70. WEN X, Hu Y, Liu Y, Li Z, et al
    Conservative treatment of head and neck lymphoma is not the only effective treatment: A retrospective analysis of 301 cases.
    Oral Oncol. 2022;128:105828.
    PubMed     Abstract available


    April 2022
  71. GALLOGLY JA JR, Weber AK, Mazul AL, Brinkmeier JV, et al
    Inferior outcomes associated with emergency department presentation for head and neck cancer surgery.
    Oral Oncol. 2022;129:105894.
    PubMed     Abstract available


  72. SHE L, Tian K, Han J, Zuo W, et al
    Pembrolizumab with or without chemotherapy versus cetuximab plus chemotherapy to treat recurrent or metastatic head and neck squamous cell carcinoma: An updated KEYNOTE-048 based cost-effectiveness analysis.
    Oral Oncol. 2022;129:105871.
    PubMed     Abstract available


  73. KATO A, Matsuda Y, Morioka R, Okui T, et al
    Discrepancy between subjective and objective postoperative oral dysfunction assessment after oral cancer treatment: A single-center cross-sectional study.
    Oral Oncol. 2022;129:105879.
    PubMed     Abstract available


  74. HAIST C, Poschinski Z, Bister A, Hoffmann MJ, et al
    Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas.
    Oral Oncol. 2022;129:105867.
    PubMed     Abstract available


  75. SEKAR D, Panagal M, Manimaran D, Ahmad N, et al
    miR-185 and its anti-miR as a biomarker and therapeutic target for oral cancer.
    Oral Oncol. 2022;129:105873.
    PubMed    


  76. LIU T, Ma L, Song L, Yan B, et al
    CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;129:105858.
    PubMed     Abstract available


  77. NERALLA M, Senthilnthan P, Kubendiran D, Nandan A, et al
    Dry needle therapy for post operative shoulder dysfunction in oral cancer patients.
    Oral Oncol. 2022;128:105865.
    PubMed    


  78. PETRELLI F, Trevisan F, Ghidini A, Capriotti V, et al
    Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis.
    Oral Oncol. 2022;128:105864.
    PubMed    


  79. ZHOU S, Chan C, Rulach R, Dyab H, et al
    Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
    Oral Oncol. 2022;128:105870.
    PubMed     Abstract available


  80. YANG ZC, Nie ZQ, Chen QY, Du CC, et al
    Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission.
    Oral Oncol. 2022;128:105851.
    PubMed     Abstract available


  81. FENG G, Feng H, Qi Y, Wang T, et al
    Interaction analysis between germline genetic variants and somatic mutations in head and neck cancer.
    Oral Oncol. 2022;128:105859.
    PubMed     Abstract available


  82. CHEN Y, Zheng X, Lin J, Gao X, et al
    A high homologous recombination deficiency score is associated with poor survival and a non-inflamed tumor microenvironment in head and neck squamous cell carcinoma patients.
    Oral Oncol. 2022;128:105860.
    PubMed     Abstract available


  83. TIAN K, Han J, Wang Z, Chen J, et al
    Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis.
    Oral Oncol. 2022;128:105842.
    PubMed     Abstract available


  84. BALACHANDER K, Roy A, Priyadharsini JV, Murugan S, et al
    Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer.
    Oral Oncol. 2022;128:105857.
    PubMed    


  85. DE LA COUR CD, Munk C, Aalborg GL, Kjaer SK, et al
    Base of tongue/tonsillar and laryngeal cancer in Denmark 1994-2018: Temporal trends in incidence according to education and age.
    Oral Oncol. 2022;128:105832.
    PubMed     Abstract available


  86. BANERJEE A, Misra SR, Roy B, Singh S, et al
    Central oral histopathology registry (COHR) - A proposal promising hope for oral cancer and oral pathology research.
    Oral Oncol. 2022;128:105856.
    PubMed    


  87. SEKAR D, Murthykumar K, Ganapathy D
    miR-206 and its mimics: A predictive biomarker and therapeutic molecule in the treatment of oral cancer.
    Oral Oncol. 2022;128:105849.
    PubMed    


  88. RISCHIN D, Harrington KJ, Greil R, Soulieres D, et al
    Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
    Oral Oncol. 2022;128:105815.
    PubMed     Abstract available


  89. VAIDYA K, Sarode SC, Gadre P, Gadre K, et al
    Mammary analogue secretory carcinoma presenting as localized hematoma of the palate.
    Oral Oncol. 2022;127:105821.
    PubMed    


  90. BIJAI LK, Muthukrishnan A
    Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis.
    Oral Oncol. 2022;127:105810.
    PubMed     Abstract available


  91. NAMRATA D, Lakshmi T, Rushabh D, Ezhilarasan D, et al
    Role of stress management in oral malignant and premalignant conditions.
    Oral Oncol. 2022;127:105813.
    PubMed    


  92. DE SOUZA GP, Santos MM, Ferreira IN, Cunha JLS, et al
    Oral basaloid squamous cell carcinoma: A case report with emphasis on histopathological diagnosis criteria.
    Oral Oncol. 2022;127:105814.
    PubMed     Abstract available


  93. SEKAR D
    Implications of long non-coding RNAs (lncRNAs) in the treatment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;127:105812.
    PubMed    


  94. TANS L, Al-Mamgani A, Kwa SLS, Elbers JBW, et al
    Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile.
    Oral Oncol. 2022;127:105782.
    PubMed     Abstract available


  95. BRINKMAN D, Callanan D, Jawad H, O'Sullivan R, et al
    Comparison of royal college of pathologists and college of american pathologists definition for positive margins in oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;127:105797.
    PubMed     Abstract available


  96. ROH JL
    Gland-preserving surgery of benign parotid tumours via postauricular sulcus incision: Is it safe and effective with the scarless incision?
    Oral Oncol. 2022;127:105808.
    PubMed     Abstract available


  97. WANG SJ, Shen SY, Lin B, Wang F, et al
    Factors affecting postoperative sleep quality of patients undergoing flap transfer for head and neck reconstruction.
    Oral Oncol. 2022;127:105804.
    PubMed     Abstract available


  98. SARODE SC, Sarode GS, Sharma NK
    Salivary gland carcinomas and molecular chaos: Additional perspectives.
    Oral Oncol. 2022;127:105802.
    PubMed    


  99. SEKAR D
    The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD).
    Oral Oncol. 2022;127:105786.
    PubMed    


  100. LIN A, Helgeson ES, Treister NS, Schmidt BL, et al
    The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study.
    Oral Oncol. 2022;127:105783.
    PubMed     Abstract available


  101. COMER JC, King RB, Harris AB, Hitchcock KE, et al
    Retromolar trigone squamous cell carcinoma: A population-based analysis of survival.
    Oral Oncol. 2022;127:105767.
    PubMed     Abstract available


  102. YANG Q, Cheng C, Zhu R, Guo F, et al
    A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis.
    Oral Oncol. 2022;127:105771.
    PubMed     Abstract available


  103. EGAL ESA, Scarini JF, de Lima-Souza RA, Lavareze L, et al
    Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos.
    Oral Oncol. 2022;127:105777.
    PubMed     Abstract available


  104. DODDAWAD VG, Premalatha BR, Sreeshyla HS, Nitin P, et al
    Classification staging systems on clinical and radiographic features of inverted sinonasal papilloma: A case report.
    Oral Oncol. 2022;127:105768.
    PubMed     Abstract available


    March 2022
  105. PATIL V, Noronha V, Joshi A, Menon N, et al
    RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.
    Oral Oncol. 2022;128:105816.
    PubMed     Abstract available


  106. CHANG CT, Liu SP, Muo CH, Liao YF, et al
    The impact of dental therapy timelines and irradiation dosages on osteoradionecrosis in oral cancer patients: A population-based cohort study.
    Oral Oncol. 2022;128:105827.
    PubMed     Abstract available


  107. HSIEH MC, Wang CC, Yang CC, Lien CF, et al
    The role of induction chemotherapy in patients with locally advanced head and neck squamous cell carcinoma: A nationwide population-based matched study.
    Oral Oncol. 2022;128:105848.
    PubMed     Abstract available


  108. YANG X, Xu X, Zhang C, Ji T, et al
    The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring.
    Oral Oncol. 2022;128:105846.
    PubMed     Abstract available


  109. RANJAN MISRA S, Das R
    Tele-screening for early detection of oral cancer during the COVID-19 pandemic era: Diagnostic pitfalls and potential misinterpretations!
    Oral Oncol. 2022;128:105845.
    PubMed    


  110. MATTOX AK, D'Souza G, Khan Z, Allen H, et al
    Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.
    Oral Oncol. 2022;128:105805.
    PubMed     Abstract available


  111. BALACHANDER K, Paramasivam A
    Cell-free mitochondrial DNA as a novel non-invasive biomarker for oral cancer.
    Oral Oncol. 2022;127:105825.
    PubMed    


  112. YAMAGUMA Y, Kaneuji T, Shirouzu S, Fukui T, et al
    Combination therapy of Mohs paste and chemotherapy improved metastatic oral cancer to the precordium skin and bilateral axillary lymph nodes: A case report.
    Oral Oncol. 2022;127:105817.
    PubMed     Abstract available


  113. VILLARD A, Breuskin I, Casiraghi O, Asmandar S, et al
    Confocal laser endomicroscopy and confocal microscopy for head and neck cancer imaging: Recent updates and future perspectives.
    Oral Oncol. 2022;127:105826.
    PubMed     Abstract available


  114. PATIL V, Alone M, Rai R, Noronha V, et al
    Safety and efficacy of pembrolizumab with chemotherapy in locally advanced head and neck cancers.
    Oral Oncol. 2022;127:105824.
    PubMed    


  115. DE LUCA P, Di Stadio A, Tassone D, de Campora L, et al
    Large cervical mass and head and neck cancer. First report of ectopic papillary adenoma of the lung.
    Oral Oncol. 2022;127:105823.
    PubMed     Abstract available


  116. DEVARAJA K, Kabekkodu SP
    Oral microbiome; a potential game-changer in the management of oral cancer?
    Oral Oncol. 2022;127:105822.
    PubMed    


  117. BONETTI VALENTE V, Mantovan Mazzon B, Urbano Collado F, Conrado Neto S, et al
    Clinicopathological and prognostic profile of non-smoking and non-drinking head and neck cancer patients: a population-based comparative study.
    Oral Oncol. 2022;127:105799.
    PubMed     Abstract available


  118. SHETH S, Gilbert J, Deal AM, Chera B, et al
    Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105807.
    PubMed    


  119. VALERO C, Yuan A, Zanoni DK, Lei E, et al
    Young non-smokers with oral cancer: What are we missing and why?
    Oral Oncol. 2022;127:105803.
    PubMed     Abstract available


  120. ELUMALAI P, Ezhilarasan D, Lakshmi T
    Targeting head and neck cancer epigenetics with CRISPR-dCas9: An emerging therapeutic approach.
    Oral Oncol. 2022;127:105801.
    PubMed    


  121. GLAZAR DJ, Johnson M, Farinhas J, Steuer CE, et al
    Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab.
    Oral Oncol. 2022;127:105787.
    PubMed     Abstract available


  122. ROUTILA J, Qiao X, Weltner J, Rantala JK, et al
    Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105772.
    PubMed     Abstract available


  123. BRODY RM, Shimunov D, Cohen RB, Lin A, et al
    A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
    Oral Oncol. 2022;127:105798.
    PubMed     Abstract available


  124. GONCALVES JM, Scarini JF, Gondak R, Altemani A, et al
    Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
    Oral Oncol. 2022;126:105779.
    PubMed     Abstract available


  125. I GHANEM A, Woody NM, Schymick MA, Joshi NP, et al
    Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study.
    Oral Oncol. 2022;126:105781.
    PubMed     Abstract available


  126. LOMBARDI D, Tomasoni M, Lorini L, Gurizzan C, et al
    Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.
    Oral Oncol. 2022;126:105764.
    PubMed     Abstract available


  127. CALABRESE L, Nocini R, Spirito F, Gazzini L, et al
    The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations.
    Oral Oncol. 2022;126:105751.
    PubMed    


  128. AL-LAMI A, Gao C, Saddiq M, Al Zuhir N, et al
    Reducing the unknowns: A systematic review & meta-analysis of the effectiveness of trans-oral surgical techniques in identifying head and neck primary cancer in carcinoma unknown primary.
    Oral Oncol. 2022;126:105748.
    PubMed     Abstract available


  129. SEKAR D
    Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;126:105763.
    PubMed    


  130. SILVA LC, Faustino ISP, Cantadori GR, Santos-Silva AR, et al
    Adenocarcinoma not otherwise specified (NOS) arising in the sublingual gland: Rare case report and follow-up.
    Oral Oncol. 2022;126:105754.
    PubMed     Abstract available


  131. KANG CJ, Wen YW, Lee SR, Ng SH, et al
    Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Oral Oncol. 2022;126:105750.
    PubMed     Abstract available


  132. SAKTHIVEL P, Raveendran S, Rajeshwari M
    Sinonasal small round blue cell tumors: What the clinician must know!
    Oral Oncol. 2022;126:105735.
    PubMed    


  133. YUWANATI M, Sarode SC, Sarode GS, Gadbail A, et al
    Clinical trial outcomes in oral squamous cell carcinoma: A pragmatic ideation.
    Oral Oncol. 2022;126:105752.
    PubMed    


  134. CHAGAS-NETO JL, Nogueira DPS, Santos-Neto AGD, Duarte IX, et al
    Hyalinizing clear cell carcinoma of minor salivary glands: A case report with uncommon presentation.
    Oral Oncol. 2022;126:105753.
    PubMed     Abstract available


  135. E C, M D, K C, V A, et al
    Trismus therapy devices: A systematic review.
    Oral Oncol. 2022;126:105728.
    PubMed     Abstract available


  136. NAYYAR V, Bhutia O, Kakkar A, Mishra D, et al
    Primary intraosseous oncocytic mucoepidermoid carcinoma of the jaw: First case report.
    Oral Oncol. 2022;126:105732.
    PubMed    


  137. RAMOS-GARCIA P, Gonzalez-Moles MA, Warnakulasuriya S
    Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis.
    Oral Oncol. 2022;126:105734.
    PubMed     Abstract available


    February 2022
  138. QURESHI HA, Zhu X, Yang GH, Steadele M, et al
    Impact of HPV status on immune responses in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105774.
    PubMed     Abstract available


  139. BELGIOIA L, Becherini C, Bacigalupo A, Bonomo P, et al
    Chemo- immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?
    Oral Oncol. 2022;127:105773.
    PubMed     Abstract available


  140. DAGLINAMRATA, Lakshmi T, Rushabh D, Dineshkumar T, et al
    Telescreening as an alternate modality for early detection of oral cancer.
    Oral Oncol. 2022;127:105785.
    PubMed    


  141. HARING CT, Dermody SM, Yalamanchi P, Kang SY, et al
    The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;126:105776.
    PubMed     Abstract available


  142. MICHMERHUIZEN NL, Heenan C, Wang J, Leonard E, et al
    Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model.
    Oral Oncol. 2022;126:105770.
    PubMed    


  143. MADY LJ, Baddour K, Hodges JC, Magana LC, et al
    The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm.
    Oral Oncol. 2022;126:105766.
    PubMed     Abstract available


  144. ZHANG S, Zhang W, Zhang J
    Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;126:105755.
    PubMed     Abstract available


  145. LI JL, Hsieh TL, Ou MC, Lin FC, et al
    Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients.
    Oral Oncol. 2022;126:105729.
    PubMed    


  146. LENOCI D, Carenzo A, Cavalieri S, Pistore F, et al
    Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.
    Oral Oncol. 2022;126:105756.
    PubMed    


  147. CHAN SK, Lin C, Huang SH, Chau TC, et al
    Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
    Oral Oncol. 2022;126:105736.
    PubMed     Abstract available


  148. VAN MUNSTER MH, de Bree R, Breimer GE, Van Cann EM, et al
    Surgical margins in the resection of oral squamous cell carcinoma under local versus general anesthesia.
    Oral Oncol. 2022;125:105724.
    PubMed     Abstract available


  149. KRISHNA A, Singh S, Kumar V
    Prognostic impact of Beta-2 Adrenergic Receptor in oral squamous cell carcinoma.
    Oral Oncol. 2022;125:105720.
    PubMed    


  150. SILVERMAN DA, Parikh AS, Liu K, Zhan KY, et al
    Predictors of survival following carotid blowout syndrome.
    Oral Oncol. 2022;125:105723.
    PubMed     Abstract available


  151. ZOTTI F, Nocini R, Capocasale G, Fior A, et al
    Response to a Comment on "Malignant transformation evidences of Oral Lichen Planus: When the time is of the essence".
    Oral Oncol. 2022;125:105714.
    PubMed    


  152. TEZ M
    Chronic mechanical irritation and oral squamous cell carcinoma: Let's look from evolutionary perspective.
    Oral Oncol. 2022;125:105727.
    PubMed    


  153. GANAPATHY D, Ramadoss R, Yuwanati M, Karthikeyan M, et al
    Rarity of mucormycosis in oral squamous cell carcinoma: A clinical paradox?
    Oral Oncol. 2022;125:105725.
    PubMed    


  154. CHIN O, Alshafai L, O'Sullivan B, Su J, et al
    Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma.
    Oral Oncol. 2022;125:105716.
    PubMed     Abstract available


  155. FAUSTINO ISP, Georgaki M, Santos-Silva AR, Vargas PA, et al
    Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis.
    Oral Oncol. 2022;125:105710.
    PubMed     Abstract available


  156. MENDEZ AI, Wihlidal JGJ, Eurich DT, Nichols AC, et al
    Validity of functional patient-reported outcomes in head and neck oncology: A systematic review.
    Oral Oncol. 2022;125:105701.
    PubMed     Abstract available


  157. SARODE G, Sarode SC, Sharma NK
    Phenotypic reflection of white sponge nevus in histomorphological features of oral squamous cell carcinoma.
    Oral Oncol. 2022;125:105707.
    PubMed    


  158. MISRA SR, Mishra N, Satpathy SK
    Primary oral melanoma: ABCDE or AEIOU criteria for clinical diagnosis?
    Oral Oncol. 2022;125:105706.
    PubMed    


  159. VAN WEERT S, Valstar M, Lissenberg-Witte B, Bloemena E, et al
    Prognostic factors in acinic cell carcinoma of the head and neck: The Amsterdam experience.
    Oral Oncol. 2022;125:105698.
    PubMed     Abstract available


  160. CHEN TC, Wang C, Su LY, Lin MC, et al
    Impact of invasion into cervical esophagus for patients with hypopharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;125:105683.
    PubMed     Abstract available


  161. SAWHNEY S, Thiagarajan S, Balaji A, Sathe P, et al
    Results of sequential swallowing assessments in patients undergoing upfront surgery for oral tongue squamous cell carcinoma.
    Oral Oncol. 2022;125:105684.
    PubMed     Abstract available


  162. FERREIRA PS, Rocha L, Bezerra APC, Nico MMS, et al
    Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study.
    Oral Oncol. 2022;125:105674.
    PubMed     Abstract available


    January 2022
  163. SENGUPTA N, Sarode SC, Sarode GS, Ghone U, et al
    Scarcity of publicly available oral cancer image datasets for machine learning research.
    Oral Oncol. 2022;126:105737.
    PubMed     Abstract available


  164. JONAS H, Simnica D, Bussmann L, Zech H, et al
    Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HN.
    Oral Oncol. 2022;126:105733.
    PubMed    


  165. SEKAR D
    Inhibition of OSCC derived ExomiRs and its therapeutic applications in oral cancer.
    Oral Oncol. 2022;126:105747.
    PubMed    


  166. FERRAZZO KL
    Regarding: "Clinical practice guidelines for dental management prior to radiation for head and neck cancer".
    Oral Oncol. 2022;126:105731.
    PubMed    


  167. WARD MC, Miller JA, Walker GV, Moeller BJ, et al
    The economic impact of circulating tumor-tissue modified HPV DNA for the post-treatment surveillance of HPV-driven oropharyngeal cancer: A simulation.
    Oral Oncol. 2022;126:105721.
    PubMed     Abstract available


  168. LIU X, Li WF, Ding C, Chen L, et al
    Differential benefit of induction chemotherapy according to body mass index in nasopharyngeal carcinoma - Pooled analysis of two randomized trials.
    Oral Oncol. 2022;125:105718.
    PubMed     Abstract available


  169. K AP, Selvakumar SC, Selvaraj J, Mony U, et al
    Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics.
    Oral Oncol. 2022;125:105713.
    PubMed    


  170. ECONOMOPOULOU P, Kotsantis I, Psyrri A
    Radiotherapy and immunotherapy combination in head and neck cancer: Does current failure qualify as an ending or is it a key to future success?
    Oral Oncol. 2022 Jan 13:105717. doi: 10.1016/j.oraloncology.2022.105717.
    PubMed    


  171. CARDIN GB, Bernard M, Bourbonnais J, Bahig H, et al
    The rs6942067 genotype is associated with a worse overall survival in young or non-smoking HPV-negative patients with positive nodal status in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;125:105696.
    PubMed    


  172. GILLIGAN G, Piemonte E, Lazos J, Panico R, et al
    Chronic wounds of traumatic origin and oral cancer arising de novo: A potential association?
    Oral Oncol. 2022;125:105711.
    PubMed    


  173. PATIL V, Ghandade N, Noronha V, Menon N, et al
    Hypomagnesemia in patients with locally advanced head and neck cancer treated weekly cisplatin-incidence and impact on outcomes.
    Oral Oncol. 2022;125:105709.
    PubMed    


  174. D'ASCANIO L, Latini G, Pandolfini M, Imperatori L, et al
    Covid-19 negatively impacted on small oncology surgery but none on major procedures: Regional experience.
    Oral Oncol. 2022;124:105439.
    PubMed     Abstract available


  175. RAMDOSS R, Yuwanati M, Viola E A, Ramani P, et al
    Can koilocytes without dysplasia in OPMDs be an early indicator and prognostic factor for oral squamous cell carcinoma?
    Oral Oncol. 2022;124:105672.
    PubMed    


  176. SARODE GS, Sarode SC, Yuwanati M, Gadbail A, et al
    Lichenoid infiltrate in oral submucous fibrosis: A new marker of malignant transformation.
    Oral Oncol. 2022;124:105671.
    PubMed    


  177. SANTANA T, Correia Neto IJ, Sugaya NN, Trierveiler M, et al
    Myoepithelial carcinoma of the minor salivary glands: A case report of a rare tumor.
    Oral Oncol. 2022;124:105667.
    PubMed    


  178. VIITASALO S, Karhemo PR, Vaananen J, Ilmarinen T, et al
    Exome sequencing reveals candidate mutations implicated in sinonasal carcinoma and malignant transformation of sinonasal inverted papilloma.
    Oral Oncol. 2022;124:105663.
    PubMed     Abstract available


  179. PANTA P, Misra SR
    Chronic mechanical irritation and oral squamous cell carcinoma: A case series.
    Oral Oncol. 2022;124:105669.
    PubMed    


  180. XAVIER-JUNIOR JCC, Ocanha-Xavier JP, Asato MA, Bernabe DG, et al
    The 'AEIOU' system to identify primary oral melanoma.
    Oral Oncol. 2022;124:105670.
    PubMed     Abstract available


  181. SAKTHIVEL P, Thakar A, Fernandez-Fernandez MM, Panda S, et al
    TransOral UltraSonic surgery (TOUSS) for oral cavity, oropharyngeal and supraglottic malignancy: A prospective study of feasibility, safety, margins, functional and survival outcomes.
    Oral Oncol. 2022;124:105643.
    PubMed     Abstract available


  182. KIM TH, Eun YG, Lee YC
    A machine learning based survival prediction model for advanced parotid gland mucoepidermoid carcinoma.
    Oral Oncol. 2022;124:105664.
    PubMed    


  183. MISRA SR, Das R
    Comment on "Oral squamous cell carcinoma due to chronic mechanical irritation."
    Oral Oncol. 2022;124:105661.
    PubMed    


  184. DE FELICE F, Botticelli A
    Cetuximab: Its role in patients unfit for cisplatin.
    Oral Oncol. 2022;124:105654.
    PubMed    


  185. ZANONI DK, Valero C, McGill MR, Montero PH, et al
    Distant metastasis in oral squamous cell carcinoma: Does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status?
    Oral Oncol. 2022;124:105641.
    PubMed     Abstract available


  186. ABBASI AI, Shetty SS, de Arruda JAA
    Autotransplantation of teeth: An alternative for patients with malignant transformation of oral submucous fibrosis.
    Oral Oncol. 2022;124:105644.
    PubMed    


  187. LI MM, Mroz EA, Faquin WC, Lott-Limbach A, et al
    ERalpha: A biomarker and treatment target for oropharyngeal cancer?
    Oral Oncol. 2022;124:105637.
    PubMed    


  188. RAMADOSS R, Yuwanati M, Ramani P, Krishnan R, et al
    Glandular metaplasia in oral squamous cell carcinoma: Prognostic indicators? Deriving inference from urothelial and breast carcinoma.
    Oral Oncol. 2022;124:105639.
    PubMed    


  189. FAKHRAEI S, Layegh P, Darchini-Maragheh E, Tayyebi Meybodi N, et al
    Oral verrucous carcinoma arising from pemphigus vulgaris: A rare coincidence.
    Oral Oncol. 2022;124:105513.
    PubMed    


  190. MALIK A, Panda S, Sakthivel P
    Treatment of early glottic carcinoma: Is it a paradox of choices?
    Oral Oncol. 2022;124:105516.
    PubMed    


  191. PANDIAR D, Ramani P, Krishnan RP, Thamilselvan S, et al
    Spindle cell squamous cell carcinoma of alveolus with heterologous mesenchymal differentiation and synchronous contralateral buccal squamous cell carcinoma in a background of oral submucous fibrosis: Recapitulation of embryonic plasticity?
    Oral Oncol. 2022;124:105476.
    PubMed    


  192. VARGHESE BT
    Head and neck surgical oncology training in the current era of molecular oncology.
    Oral Oncol. 2022;124:105474.
    PubMed     Abstract available


  193. ZHANG L, Chen L, Xiao M, Xie X, et al
    Locally advanced undifferentiated sarcomatoid carcinoma of the right maxillary sinus with PDCD6-TERT fusion: A rare case report.
    Oral Oncol. 2022;124:105466.
    PubMed     Abstract available


    December 2021
  194. COHEN O, Brauer PR, Judson BL, Burtness BA, et al
    Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival - A National study.
    Oral Oncol. 2021;125:105694.
    PubMed     Abstract available


  195. WANG J, Tian Y, Huang H, Huang D, et al
    The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
    Oral Oncol. 2021;125:105675.
    PubMed     Abstract available


  196. SUBASH A, Bylapudi B, Thakur S, Rao VUS, et al
    Oral cancer in India, a growing problem: Is limiting the exposure to avoidable risk factors the only way to reduce the disease burden?
    Oral Oncol. 2021;125:105677.
    PubMed     Abstract available


  197. MERCHANT YP, Mohan M, Shetty S, Bandemegal M, et al
    The submandibular gland in neck dissection: A necessary casualty or a hapless victim?
    Oral Oncol. 2021;125:105678.
    PubMed    


  198. HERNDON P, Jassal JS, Cramer JD
    Association between E-cigarette use and oral HPV-16 infection.
    Oral Oncol. 2021;125:105676.
    PubMed    


  199. DOU Y, Ma C, Wang K, Liu S, et al
    Dysbiotic tumor microbiota associates with head and neck squamous cell carcinoma outcomes.
    Oral Oncol. 2021;124:105657.
    PubMed     Abstract available


  200. NOJI R, Kano Y, Hirai H, Onishi I, et al
    MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma.
    Oral Oncol. 2021;124:105666.
    PubMed     Abstract available


  201. WEI LY, Lin HC, Tsai FC, Ko JY, et al
    Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival.
    Oral Oncol. 2021;124:105665.
    PubMed     Abstract available


  202. SARI SY, Yilmaz MT, Aktas BY, Aksoy S, et al
    Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience.
    Oral Oncol. 2021;124:105658.
    PubMed     Abstract available


  203. CRAMER JD, Grauer J
    Modeling oral cancer screening in the United States population.
    Oral Oncol. 2021;124:105656.
    PubMed     Abstract available


  204. BIGELOW EO, Windon MJ, Fakhry C, Kiess AP, et al
    Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.
    Oral Oncol. 2021;123:105618.
    PubMed     Abstract available


  205. CAI X, Zhang J, Han Y, Tang Q, et al
    Development and validation of a nomogram prediction model for malignant transformation of oral potentially malignant disorders.
    Oral Oncol. 2021;123:105619.
    PubMed     Abstract available


  206. ROMINE PE, Voutsinas J, Wu V, Tratt M, et al
    Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.
    Oral Oncol. 2021;123:105626.
    PubMed     Abstract available


  207. BURNINGHAM K, Moore W, Moon D, Avkshtol V, et al
    Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Oral Oncol. 2021;123:105623.
    PubMed     Abstract available


  208. GHONE U, Sarode GS, Sengupta N, Sarode SC, et al
    Oral potentially malignant disorder and regular follow-up: Importance well understood with poor translation.
    Oral Oncol. 2021;123:105630.
    PubMed    


  209. MISHRA S, Thakur S, Rao VUS, Subash A, et al
    Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study.
    Oral Oncol. 2021;123:105614.
    PubMed    


  210. BYLAPUDI B, Rao VUS, Subash A, Thakur S, et al
    Does SLNB substitute END in the future with the sole advantage of preventing shoulder morbidity?
    Oral Oncol. 2021;123:105628.
    PubMed     Abstract available


  211. BERGER J, Zech HB, Hoffer K, von Bargen CM, et al
    Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors.
    Oral Oncol. 2021;123:105603.
    PubMed     Abstract available


  212. NOEL CW, Forner D, Chepeha DB, Baran E, et al
    The Edmonton Symptom Assessment System: A narrative review of a standardized symptom assessment tool in head and neck oncology.
    Oral Oncol. 2021;123:105595.
    PubMed     Abstract available


  213. CHENG NM, Kang CJ, Tsai CY, Lee LY, et al
    Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.
    Oral Oncol. 2021;123:105593.
    PubMed     Abstract available


  214. MIMICA X, Yuan A, Hay A, Katabi N, et al
    Mucoepidermoid carcinoma: Evaluating the prognostic impact of primary tumor site.
    Oral Oncol. 2021;123:105602.
    PubMed     Abstract available


  215. SIVANANDAN N, Nagarajan M, Roy A, Subramaniam A, et al
    Invasive oral squamous cell carcinoma of maxillary alveolus in a Nicobari tribal woman after 17 years of tobacco cessation - A case report.
    Oral Oncol. 2021;123:105601.
    PubMed    


  216. PANTA P
    Oral squamous cell carcinoma due to chronic mechanical irritation.
    Oral Oncol. 2021;123:105616.
    PubMed    


  217. VAN DER WAAL I
    The term 'Proliferative verrucous leukoplakia' should be abandoned and this is why.
    Oral Oncol. 2021;123:105621.
    PubMed    


  218. FUSSEY J, Tomasoni M, Tirelli G, Giordano L, et al
    Prognostic indicators in clinically node-negative malignant primary salivary tumours of the parotid: A multicentre experience.
    Oral Oncol. 2021;123:105577.
    PubMed     Abstract available


  219. VARGHESE BT
    Rearterialized islanded facial artery muco-muscular flap (iFAMM) flap in tongue reconstruction.
    Oral Oncol. 2021;123:105592.
    PubMed    


  220. LIU S, Bellile E, Nguyen A, Zarins K, et al
    Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen.
    Oral Oncol. 2021;123:105587.
    PubMed     Abstract available


  221. JIMENEZ JE, Nilsen ML, Gooding WE, Anderson JL, et al
    Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity.
    Oral Oncol. 2021;123:105574.
    PubMed     Abstract available


  222. MERCHANT YP, Subash A, Rao VUS
    Unravelling parotid metastasis in oral squamous cell carcinoma - Do they warrant inclusion in Staging?
    Oral Oncol. 2021;123:105581.
    PubMed    


  223. ARUN P, Arun I, Jain P, Manikantan K, et al
    Determinants of prognosis in patients with oral squamous cell carcinoma metastasizing to a single cervical lymph node.
    Oral Oncol. 2021;123:105586.
    PubMed     Abstract available


  224. ASODA S, Miyashita H, Soma T, Munakata K, et al
    Clinical value of entire-circumferential intraoperative frozen section analysis for the complete resection of superficial squamous cell carcinoma of the tongue.
    Oral Oncol. 2021;123:105629.
    PubMed     Abstract available


    November 2021
  225. GUPTA T, Maheshwari G, Kannan S, Nair S, et al
    Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for pract
    Oral Oncol. 2021;124:105642.
    PubMed     Abstract available


  226. CHAUHAN A, Kaur R, Ghoshal S, Chatterjee D, et al
    Potential prognostic and predictive role of baseline circulating tumor cells in head and neck squamous cell carcinoma.
    Oral Oncol. 2021;124:105636.
    PubMed    


  227. FUEREDER T, Minichsdorfer C, Mittlboeck M, Wagner C, et al
    Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study.
    Oral Oncol. 2021;124:105634.
    PubMed     Abstract available


  228. DENARO N, Merlano M, Garrone O
    In reply to immune desert in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.
    Oral Oncol. 2021;124:105640.
    PubMed    


  229. THADURI A, Dungala D, Panuganti A, Majumdar KS, et al
    Addressing the challenges of head and neck cancer care in India - A compelling need of the hour.
    Oral Oncol. 2021;124:105638.
    PubMed    


  230. MADHULAXMI M, Abhinav RP
    Protein changes of WNT signaling pathway in oral cancer.
    Oral Oncol. 2021;123:105624.
    PubMed    


  231. KOWALCHUK RO, Van Abel KM, Yin LX, Garcia J, et al
    Correlation between radiographic and pathologic lymph node involvement and extranodal extension via CT and PET in HPV-associated oropharyngeal cancer.
    Oral Oncol. 2021;123:105625.
    PubMed     Abstract available


  232. GAU M, Fonseca A, Ozsahin M, Fayette J, et al
    Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study.
    Oral Oncol. 2021;123:105605.
    PubMed     Abstract available


  233. MISHRA S, Subash A, Rao VUS, Thakur S, et al
    Role of neoadjuvant chemotherapy in head and neck cancer management: A case for exploring diverse treatment strategies for evaluating long-term efficacy.
    Oral Oncol. 2021;123:105594.
    PubMed    


  234. GOLUSINSKI P, Corry J, Poorten VV, Simo R, et al
    De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
    Oral Oncol. 2021;123:105620.
    PubMed     Abstract available


  235. WATSON E, Dorna Mojdami Z, Oladega A, Hope A, et al
    Clinical practice guidelines for dental management prior to radiation for head and neck cancer.
    Oral Oncol. 2021;123:105604.
    PubMed     Abstract available


  236. BRIL SI, Chargi N, Wendrich AW, Wegner I, et al
    Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
    Oral Oncol. 2021;123:105617.
    PubMed     Abstract available


  237. WANG Y, Gao Y, Yuan L, Zhang J, et al
    Psychological needs and associated factors among perioperative patients with oral cancer.
    Oral Oncol. 2021;123:105615.
    PubMed    


  238. JOY A, Rao VUS
    Reply: Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection.
    Oral Oncol. 2021;122:105535.
    PubMed    


  239. SHAH A, Sumer BD, Schostag K, Balachandra S, et al
    Institutional patterns of head and neck oncology care during the early phase of the COVID-19 pandemic: A retrospective, pooled cross-sectional analysis.
    Oral Oncol. 2021;122:105564.
    PubMed    


  240. LIAO CT, Yang LY, Lee LY, Lin CY, et al
    Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
    Oral Oncol. 2021;122:105547.
    PubMed     Abstract available


  241. GRONLUND MP, Jakobsen KK, Mirian C, Gronhoj C, et al
    Nasopharyngeal malignancies in Denmark diagnosed from 1980 to 2014.
    Oral Oncol. 2021;122:105583.
    PubMed     Abstract available


  242. YU J, Tsay C, Sasaki C, Son YH, et al
    Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs.
    Oral Oncol. 2021;122:105585.
    PubMed     Abstract available


  243. SEE A, Chu C, Kiong KL, Teo C, et al
    Surgical salvage of recurrent nasopharyngeal cancer- a multi-institutional review.
    Oral Oncol. 2021;122:105556.
    PubMed    


  244. SAKTHIVEL P, Ramanikanth TV, Thakar A, Singh CA, et al
    TransOral UltraSonic Surgery (TOUSS) assisted supraglottic laryngectomy: Expanding the spectrum of endoscopic head and neck surgeries.
    Oral Oncol. 2021;122:105562.
    PubMed    


  245. RODRIGUES-FERNANDES CI, Arboleda LPA, Vargas PA, Lopes MA, et al
    Oral leukoplakia in adolescents: Report of a rare case and review of the literature.
    Oral Oncol. 2021;122:105565.
    PubMed     Abstract available


  246. THAKAR A, Sakthivel P, Sikka K
    TransOral UltraSonic Surgery (TOUSS) and TransOral Laser (TOL) assisted supraglottic laryngectomy (TOUSS-TOL-SGL): Improvising techniques within the transoral corridor.
    Oral Oncol. 2021;122:105573.
    PubMed    


  247. LIU W, Zhu L, Xu L, Wu L, et al
    Exophytic verrucous hyperplasia as a clinical terminology includes verrucous hyperplasia with or without epithelial dysplasia in histology.
    Oral Oncol. 2021;122:105571.
    PubMed    


  248. LIN N, Gao J, Wang H, Zhang H, et al
    Diagnostic value of indocyanine green for sentinel lymph node mapping and lymph node metastasis in oral/oropharyngeal carcinoma.
    Oral Oncol. 2021;122:105563.
    PubMed     Abstract available


  249. RE M, Tomasetti M, Monaco F, Amati M, et al
    NGS-based miRNome identifies miR-449 cluster as marker of malignant transformation of sinonasal inverted papilloma.
    Oral Oncol. 2021;122:105554.
    PubMed     Abstract available


  250. MCDOWELL L, Casswell G, Bressel M, Drosdowsky A, et al
    Symptom burden, quality of life, functioning and emotional distress in survivors of human papillomavirus associated oropharyngeal cancer: An Australian cohort.
    Oral Oncol. 2021;122:105560.
    PubMed     Abstract available


  251. MIN PARK Y, Yol Lim J, Woo Koh Y, Kim SH, et al
    Prediction of treatment outcome using MRI radiomics and machine learning in oropharyngeal cancer patients after surgical treatment.
    Oral Oncol. 2021;122:105559.
    PubMed     Abstract available


  252. SANTANA T, Custodio M, Dayla Melo Oliveira C, Dos Santos Antunes E, et al
    Parotid metastasis of clear cell renal cell carcinoma 8 years after nephrectomy.
    Oral Oncol. 2021;122:105561.
    PubMed    


  253. SHIKDAR S, Fowle E, Razaq H, Razaq W, et al
    Hormonal receptor evaluation in salivary duct adenocarcinoma.
    Oral Oncol. 2021;122:105548.
    PubMed    


  254. FERRELI F, Festa BM, Costantino A, Malvezzi L, et al
    Prevalence of occult level 2b nodal metastases in cN0 squamous cell carcinoma of the oral cavity: A systematic review and meta-analysis.
    Oral Oncol. 2021;122:105540.
    PubMed     Abstract available


  255. SINGH GK, Patil VM, Noronha V, Joshi A, et al
    Weight loss and its impact on outcome in head and cancer patients during chemo-radiation.
    Oral Oncol. 2021;122:105522.
    PubMed     Abstract available


  256. VAN LE Q, Ngo DQ, Nguyen HX, Ngo QX, et al
    Transoral robotic thyroidectomy: First case as a new technique in Vietnam.
    Oral Oncol. 2021;122:105542.
    PubMed    


  257. BULBUL MG, Tarabichi O, Parikh AS, Yoon BC, et al
    The utility of intra-oral ultrasound in improving deep margin clearance of oral tongue cancer resections.
    Oral Oncol. 2021;122:105512.
    PubMed     Abstract available


  258. PATEL V, Galloway TJ, Liu JC
    The impact of positive margin on survival in oral cavity squamous cell carcinoma.
    Oral Oncol. 2021;122:105499.
    PubMed     Abstract available


    October 2021
  259. GEORGE A, Saseendran A, Joseph ST, Gopal KR, et al
    Submandibular gland - The victim of neck dissection.
    Oral Oncol. 2021;123:105591.
    PubMed    


  260. CABEZAS-CAMARERO S, Alonso-Ovies A, Merino-Menendez S, Cabrera-Martin MN, et al
    Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer.
    Oral Oncol. 2021;123:105589.
    PubMed     Abstract available


  261. BRUIJNEN CP, de Groot LGR, Vondeling AM, de Bree R, et al
    Functional decline after surgery in older patients with head and neck cancer.
    Oral Oncol. 2021;123:105584.
    PubMed     Abstract available


  262. PUTHIYOTTIL IV, Subash A, Thakur S, Rao VUS, et al
    Elective neck dissection versus sentinel node biopsy in early oral cavity cancer - Are we ready for transition?
    Oral Oncol. 2021;123:105597.
    PubMed    


  263. SHINN JR, Carey RM, Mady LJ, Shimunov D, et al
    Sex-based differences in outcomes among surgically treated patients with HPV-related oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2021;123:105570.
    PubMed     Abstract available


  264. JOSE MARTELLI A, Assis Machado R, Medeiros Pereira W, Balduino Guimaraes Santos F, et al
    Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 2.
    Oral Oncol. 2021;123:105600.
    PubMed    


  265. YUWANATI M, Sarode SC, Gadbail A, Gondivkar S, et al
    Alcohol attributed Oral Cancer and Oral microbiome: Emerging yet neglected research domain.
    Oral Oncol. 2021;123:105596.
    PubMed    


  266. YU ST, Ge JN, Sun BH, Wei ZG, et al
    Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.
    Oral Oncol. 2021;123:105567.
    PubMed     Abstract available


  267. SHU L, Wang D, Nannapaneni S, Sun Y, et al
    Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC).
    Oral Oncol. 2021;122:105546.
    PubMed     Abstract available


  268. MA D, Orner D, Ghaly MM, Parashar B, et al
    Automated health chats for symptom management of head and neck cancer patients undergoing radiation therapy.
    Oral Oncol. 2021;122:105551.
    PubMed     Abstract available


  269. SHISHODIA G, Toledo RRG, Rong X, Zimmerman E, et al
    4NQO enhances differential activation of DNA repair proteins in HPV positive and HPV negative HNSCC cells.
    Oral Oncol. 2021;122:105578.
    PubMed     Abstract available


  270. ZHAO Y, Li WF, Li QJ, He SW, et al
    WIPI-1 inhibits metastasis and tumour growth via the WIPI-1-TRIM21 axis and MYC regulation in nasopharyngeal carcinoma.
    Oral Oncol. 2021;122:105576.
    PubMed     Abstract available


  271. ROSENBERG AJ, Agrawal N, Pearson A, Gooi Z, et al
    Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.
    Oral Oncol. 2021;122:105566.
    PubMed     Abstract available


  272. TSENG WH, Li TH, Chiu HL, Yang TL, et al
    Long-term swallowing-related outcomes in oral cancer patients receiving proactive swallowing therapy.
    Oral Oncol. 2021;122:105569.
    PubMed     Abstract available


  273. BRIL SI, van Beers MA, Chargi N, Carrillo Minulina N, et al
    Skeletal muscle mass at C3 is a strong predictor for skeletal muscle mass at L3 in sarcopenic and non-sarcopenic patients with head and neck cancer.
    Oral Oncol. 2021;122:105558.
    PubMed    


  274. PENG H, Chen L, Mao YP, Tian L, et al
    Nomogram-aided individual induction chemotherapy regimen selection in advanced nasopharyngeal carcinoma.
    Oral Oncol. 2021;122:105555.
    PubMed     Abstract available


  275. OZER NE, Ilhan B, Guneri P
    Patient specific follow-up to monitor the risk of malignant transformation on oral mucosa.
    Oral Oncol. 2021;121:105300.
    PubMed    


  276. CARNEVALE C, Pagan-Pomar A, Bianchi A, Sarria-Echegaray P, et al
    Right colonic interposition for severe pharyngoesophageal stricture in head and neck patients: A feasible rescue strategy after multiple failed reconstructive options.
    Oral Oncol. 2021;121:105481.
    PubMed     Abstract available


  277. HANS S, Chebib E, Chekkoury-Idrissi Y, Distinguin L, et al
    Surgical and oncological outcomes of transoral robotic total laryngectomy: A case series.
    Oral Oncol. 2021;121:105511.
    PubMed     Abstract available


  278. MOFFA A, Giorgi L, Costantino A, De Benedetto L, et al
    Accuracy of autofluorescence and chemiluminescence in the diagnosis of oral Dysplasia and Carcinoma: A systematic review and Meta-analysis.
    Oral Oncol. 2021;121:105482.
    PubMed     Abstract available


  279. LIU W, Yang X, Shen Z, Shi L, et al
    The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders.
    Oral Oncol. 2021;121:105479.
    PubMed    


  280. BOUCHER A, Ezzat S, Hotte S, Rachinsky I, et al
    Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.
    Oral Oncol. 2021;121:105477.
    PubMed     Abstract available


  281. CHEN HB, Gong XY, Li W, Chen DS, et al
    Genomic landscape and tumor mutation burden analysis of Chinese patients with sarcomatoid carcinoma of the head and neck.
    Oral Oncol. 2021;121:105436.
    PubMed     Abstract available


  282. PARK JO, Lee DH, Kim MR, Kim SY, et al
    Transoral endoscopic thyroidectomy using a self-retaining retractor as an alternative to carbon dioxide gas insufflation: A comparative analysis of 131 cases.
    Oral Oncol. 2021;121:105463.
    PubMed     Abstract available


  283. CHAMOLI A, Gosavi AS, Shirwadkar UP, Wangdale KV, et al
    Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics.
    Oral Oncol. 2021;121:105451.
    PubMed     Abstract available


  284. FINEGERSH A, Voora RS, Panuganti B, Faraji F, et al
    Robotic surgery may improve overall survival for T1 and T2 tumors of the hypopharynx: An NCDB cohort study.
    Oral Oncol. 2021;121:105440.
    PubMed     Abstract available


  285. GILVETTI C, Soneji C, Bisase B, Barrett AW, et al
    Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery uni
    Oral Oncol. 2021;121:105462.
    PubMed     Abstract available


  286. LI Y, Gong L, Qin N, Wei X, et al
    Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in oral squamous cell carcinoma.
    Oral Oncol. 2021;121:105437.
    PubMed     Abstract available


  287. WU T, Liu Z, Yong X, Mei G, et al
    P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review.
    Oral Oncol. 2021;121:105399.
    PubMed     Abstract available


  288. AL MASALMEH N, Kukreja G, Zaiem F, Raza SN, et al
    p16 positive oropharyngeal small cell cancer: A case report.
    Oral Oncol. 2021;121:105391.
    PubMed     Abstract available


  289. PANDIAR D, Ramani P, Krishnan RP, Monica K, et al
    Multifaceted multinucleated giant cells in oral squamous cell carcinoma.
    Oral Oncol. 2021;121:105400.
    PubMed    


  290. HARING CT, Brummel C, Bhambhani C, Jewell B, et al
    Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation.
    Oral Oncol. 2021;121:105332.
    PubMed    


    September 2021
  291. CURY SS, Miranda PM, Marchi FA, Canto LMD, et al
    Germline variants in DNA repair genes are associated with young-onset head and neck cancer.
    Oral Oncol. 2021;122:105545.
    PubMed     Abstract available


  292. WANG BC
    Adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Finding the suitable population.
    Oral Oncol. 2021 Sep 28:105544. doi: 10.1016/j.oraloncology.2021.105544.
    PubMed    


  293. SARODE SC, Sarode GS, Sengupta N, Ghone U, et al
    Tobacco induced epithelial dysplasia at minor salivary gland excretory duct and oral cancer.
    Oral Oncol. 2021;122:105525.
    PubMed    


  294. TJOA T, Rathi VK, Goyal N, Yarlagadda BB, et al
    Pneumonia, urinary tract infection, bacteremia, and Clostridioides difficile infection following major head and neck free and pedicled flap surgeries.
    Oral Oncol. 2021;122:105541.
    PubMed     Abstract available


  295. MENON N, Patil V, Noronha V, Joshi A, et al
    Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trial.
    Oral Oncol. 2021;122:105517.
    PubMed     Abstract available


  296. ZHU MY, Sun XS, Guo SS, Chen QY, et al
    Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine?
    Oral Oncol. 2021;122:105539.
    PubMed     Abstract available


  297. ZHOU X, Xu T, Yang Y, Xing X, et al
    Survival impact of increasing time to IMRT initiation following induction chemotherapy in nasopharyngeal carcinoma: A propensity score-matched analysis.
    Oral Oncol. 2021;122:105506.
    PubMed     Abstract available


  298. KIONG KL, Bell D, Yao CM, Ferrarotto R, et al
    Multifocal regression and pathologic response predicts recurrence after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
    Oral Oncol. 2021;122:105520.
    PubMed     Abstract available


  299. AJAZ S, Muneer R, Siddiqa A, Ali Memon M, et al
    Association of specific single nucleotide variants (SNVs) in the promoter and 3'-Untranslated region of Vascular Endothelial growth factor (VEGF) gene with risk and higher tumour grade of head and neck cancers.
    Oral Oncol. 2021;122:105519.
    PubMed     Abstract available


  300. TSAI TY, Chou YC, Lu YA, Kang CJ, et al
    The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
    Oral Oncol. 2021;122:105518.
    PubMed     Abstract available


  301. IDA S, Takahashi H, Kawabata-Iwakawa R, Mito I, et al
    Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
    Oral Oncol. 2021;122:105508.
    PubMed     Abstract available


  302. SAKTHIVEL P, Malik A, Panda S, Dhiwakar M, et al
    8 "S" of obturators in Head and Neck Cancer Rehabilitation during COVID-19 pandemic.
    Oral Oncol. 2021 Sep 8:105523. doi: 10.1016/j.oraloncology.2021.105523.
    PubMed    


  303. MILLIET F, Bozec A, Schiappa R, Viotti J, et al
    Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.
    Oral Oncol. 2021;122:105503.
    PubMed     Abstract available


  304. VAN HINTE G, Sancak T, Weijs WLJ, Merkx MAW, et al
    Effect of elective neck dissection versus sentinel lymph node biopsy on shoulder morbidity and health-related quality of life in patients with oral cavity cancer: A longitudinal comparative cohort study.
    Oral Oncol. 2021;122:105510.
    PubMed     Abstract available


  305. D'SOUZA ZI, Desai RS, Shirsat PM, Bansal S, et al
    Comment on "Suture line recurrence and oral squamous cell carcinoma: A viewpoint" by Sarode et al (October 2020).
    Oral Oncol. 2021;120:105297.
    PubMed    


  306. CHIDAMBARANATHAN N, Thiagarajan S
    Is it time to look beyond just the depth of invasion to decide the management of neck in early oral squamous cell carcinoma?
    Oral Oncol. 2021;120:105291.
    PubMed    


  307. MEROLLA F, Ilardi G, Di Spigna G, Russo D, et al
    Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors.
    Oral Oncol. 2021;120:105367.
    PubMed     Abstract available


  308. HERREROS-POMARES A, Llorens C, Soriano B, Zhang F, et al
    Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens.
    Oral Oncol. 2021;120:105404.
    PubMed     Abstract available


  309. LI Z, Zhang L, Liu FY, Li P, et al
    MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
    Oral Oncol. 2021;120:105401.
    PubMed     Abstract available


  310. GUDI S, O'Sullivan B, Hosni A, Su J, et al
    Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study.
    Oral Oncol. 2021;120:105419.
    PubMed     Abstract available


  311. CHEN CM, Chu TH, Chou CC, Chien CY, et al
    Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
    Oral Oncol. 2021;120:105402.
    PubMed     Abstract available


  312. SHAH S, Mahajan A, Thiagarajan S, Chidambaranathan N, et al
    Importance and implications of neurovascular bundle involvement and other MRI findings of oral tongue squamous cell carcinoma (OTSCC) on prognosis.
    Oral Oncol. 2021;120:105403.
    PubMed     Abstract available


  313. TAN LC, Yu PC, Wang J, Zhou XY, et al
    BCOR-CCNB3 rearranged sarcoma arising in neck misdiagnosed as thyroid cancer: A case report.
    Oral Oncol. 2021;120:105290.
    PubMed     Abstract available


  314. FUJIMI A, Nagamachi Y, Yamauchi N, Nishisato T, et al
    Eribulin in combination with HER2-targeted antibodies for successful treatment of metastatic salivary duct carcinoma: A report of two cases.
    Oral Oncol. 2021;120:105287.
    PubMed    


  315. DE LIMA-SOUZA RA, Scarini JF, Egal ESA, Crescencio LR, et al
    Secretory carcinoma ex pleomorphic adenoma of the submandibular gland: An immunohistochemical study.
    Oral Oncol. 2021;120:105262.
    PubMed     Abstract available


    August 2021
  316. WRIGHT CM, Lee DY, Shimunov D, Carmona R, et al
    Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
    Oral Oncol. 2021;121:105509.
    PubMed     Abstract available


  317. VERDONCK-DE LEEUW IM, Melissant H, Lissenberg-Witte BI, Baatenburg de Jong RJ, et al
    Associations between testosterone and patient reported sexual outcomes among male and female head and neck cancer patients before and six months after treatment: A pilot study.
    Oral Oncol. 2021;121:105505.
    PubMed     Abstract available


  318. SCHAIK JEV, Halmos GB, Witjes MJH, Plaat BEC, et al
    An overview of the current clinical status of optical imaging in head and neck cancer with a focus on Narrow Band imaging and fluorescence optical imaging.
    Oral Oncol. 2021;121:105504.
    PubMed     Abstract available


  319. MYATRA SN, Gupta S, D'Cruz AK, Rajanala V, et al
    Identification of patients for a delayed extubation strategy versus elective tracheostomy for postoperative airway management in major oral cancer surgery: A prospective observational study in seven hundred and twenty patients.
    Oral Oncol. 2021;121:105502.
    PubMed     Abstract available


  320. MIN Y, Xiang K, Feng Y, Chen H, et al
    Development and validation of a population-based model for predicting the regional lymph node metastasis in adolescent differentiated thyroid carcinoma.
    Oral Oncol. 2021;121:105507.
    PubMed     Abstract available


  321. YANG Q, Xia L, Lin M, Zhang MX, et al
    The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trial.
    Oral Oncol. 2021;121:105494.
    PubMed     Abstract available


  322. HOCHFELDER CG, Mehta V, Kabarriti R, McGinn AP, et al
    Survival analysis of patients with advanced hypopharyngeal cancer comparing patients who received primary surgery to those who received chemoradiation: An analysis of the NCDB.
    Oral Oncol. 2021;121:105470.
    PubMed     Abstract available


  323. BUENO DE OLIVEIRA T, Camila Braun A, Ribaldo Nicolau U, Ali Abdallah E, et al
    Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
    Oral Oncol. 2021;121:105480.
    PubMed     Abstract available


  324. NAGPAL P, Pruthi DS, Pandey M, Yadav A, et al
    Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
    Oral Oncol. 2021;121:105483.
    PubMed     Abstract available


  325. JAWERT F, Nyman J, Olsson E, Adok C, et al
    Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
    Oral Oncol. 2021;121:105469.
    PubMed     Abstract available


  326. OHKOSHI A, Ishii R, Wakamori S, Nakayama Y, et al
    Serum selenium predicts achievement of full-dose cisplatin in concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: A prospective, observational study.
    Oral Oncol. 2021;121:105475.
    PubMed     Abstract available


  327. ENGEL MSD, van der Lans RJL, Jansen JC, Leemans CR, et al
    Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic review.
    Oral Oncol. 2021;121:105465.
    PubMed     Abstract available


  328. SAKTHIVEL P, Subramanian P, Pulimala S, Panda S, et al
    A call for the universal acceptance of the modified Milan system for reporting salivary gland cytopathology.
    Oral Oncol. 2021;119:105255.
    PubMed    


  329. MCDOWELL L, Corry J
    Regarding "Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey" - Intra- and inter-specialty variability and the underutilisation o
    Oral Oncol. 2021;119:105248.
    PubMed    


  330. TRETIAKOW D, Przewozny T, Skorek A, Mikaszewski B, et al
    Regarding to "Minimaly invasive benign parotid surgery in selected patients: An adaptation example to compensate for COVID19 backlog or new era?"
    Oral Oncol. 2021;119:105227.
    PubMed    


  331. KANG CJ, Tsai CY, Lee LY, Lin CY, et al
    Prognostic stratification of patients with AJCC 2018 pStage IVB oral cavity cancer: Should pT4b and pN3 disease be reclassified?
    Oral Oncol. 2021;119:105371.
    PubMed     Abstract available


  332. PANG Y, Sun L, Liu H, Ma J, et al
    Differential diagnosis and treatment of salivary secretory carcinoma and acinic cell carcinoma.
    Oral Oncol. 2021;119:105370.
    PubMed     Abstract available


  333. HARRIS JA, Hunter WP, Ji YD, Hanna GJ, et al
    Effects of racial residential segregation on oral squamous cell carcinoma prognosis and survival.
    Oral Oncol. 2021;119:105364.
    PubMed     Abstract available


  334. FARAH CS, Fox S, Shearston K, Newman L, et al
    Lichenoid dysplasia is not a distinct pathological entity.
    Oral Oncol. 2021;119:105362.
    PubMed     Abstract available


  335. CHOI N, Kim Z, Song BH, Park W, et al
    Prediction of risk factors for pharyngo-cutaneous fistula after total laryngectomy using artificial intelligence.
    Oral Oncol. 2021;119:105357.
    PubMed     Abstract available


  336. SUBRAMANIAM N, Palme CE, Low TH
    Combined approach for malignant tumours of the deep lobe of the parotid involving the stylomandibular tunnel and parapharyngeal space.
    Oral Oncol. 2021;119:105283.
    PubMed    


  337. MARANZANO M, D'Ascanio L, Ricci G, Omer H, et al
    Misinterpretation of head and neck masses can delay the correct diagnosis. A two-step demolitive-reconstruction surgery for saving patient's life.
    Oral Oncol. 2021;119:105197.
    PubMed     Abstract available


  338. FIACCHINI G, Benettini G, Trico D, Torregrossa L, et al
    Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis.
    Oral Oncol. 2021;119:105252.
    PubMed     Abstract available


  339. SINGH N, Das S, Mehta S
    Oral tumour causing airway obstruction with stridor: Situation guided team management.
    Oral Oncol. 2021;119:105247.
    PubMed    


  340. MUNNANGI A, Kadapathri A, Pillai V, Shetty V, et al
    Should radiological staging of advanced buccal mucosa cancer preclude curative intent treatment? A prospective evaluation.
    Oral Oncol. 2021;119:105246.
    PubMed    


    July 2021
  341. MAO L, Xiao Y, Yang QC, Yang SC, et al
    TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
    Oral Oncol. 2021;121:105472.
    PubMed     Abstract available


  342. NIEUWENHUIS ER, Kolenaar B, van Bemmel AJM, Hof JJ, et al
    A complete magnetic sentinel lymph node biopsy procedure in oral cancer patients: A pilot study.
    Oral Oncol. 2021;121:105464.
    PubMed     Abstract available


  343. MATSUDA Y, Okui T, Karino M, Aoi N, et al
    Postoperative oral dysfunction following oral cancer resection and reconstruction: A preliminary cross-sectional study.
    Oral Oncol. 2021;121:105468.
    PubMed     Abstract available


  344. NAUTA IH, Klausch T, van de Ven PM, Hoebers FJP, et al
    The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis.
    Oral Oncol. 2021;121:105454.
    PubMed     Abstract available


  345. DRAKE V, Bigelow E, Fakhry C, Windon M, et al
    Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma.
    Oral Oncol. 2021;121:105461.
    PubMed     Abstract available


  346. KIM C, Martinez E, Kulich M, Swanson MS, et al
    Surgeon practice patterns in transoral robotic surgery for HPV-related oropharyngeal cancer.
    Oral Oncol. 2021;121:105460.
    PubMed     Abstract available


  347. XU Y, Chen M, Guo Q, Peng H, et al
    Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy.
    Oral Oncol. 2021;121:105435.
    PubMed     Abstract available


  348. ALMANGUSH A, Alabi RO, Makitie AA, Leivo I, et al
    Machine learning in head and neck cancer: Importance of a web-based prognostic tool for improved decision making.
    Oral Oncol. 2021 Jul 12:105452. doi: 10.1016/j.oraloncology.2021.105452.
    PubMed    


  349. KOUKETSU A, Miyashita H, Kojima I, Sakamoto M, et al
    Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers.
    Oral Oncol. 2021;120:105453.
    PubMed     Abstract available


  350. MERCHANT YP, Kudpaje A, Rao VUS
    Extent of neck dissection in the N+ neck: Adjudicating a Conundrum!
    Oral Oncol. 2021 Jul 11:105441. doi: 10.1016/j.oraloncology.2021.105441.
    PubMed    


  351. IQBAL MS, Kovarik J, Patil R, Kelly CG, et al
    Are taxanes more effective than 5FU in combination chemotherapy for recurrent and metastatic head and neck cancer?
    Oral Oncol. 2021 Jul 9:105455. doi: 10.1016/j.oraloncology.2021.105455.
    PubMed    


  352. IMADUDDIN M, Sultania M, Vigneshwaran B, Muduly DK, et al
    Psychosocial Factors in an Oral Cancer Survivor Leading to Delay in Seeking Help.
    Oral Oncol. 2021 Jul 5:105438. doi: 10.1016/j.oraloncology.2021.105438.
    PubMed    


  353. WILKIE MD, Lancaster J, Roland NJ, Jones TM, et al
    Elective management of regional nodal basins in cutaneous squamous cell carcinoma of the head and neck: Controversies and contemporary perspectives.
    Oral Oncol. 2021;120:105432.
    PubMed     Abstract available


  354. KIM SY, Beer M, Tshering Vogel DW
    Imaging in head and neck cancers: Update for non-radiologist.
    Oral Oncol. 2021;120:105434.
    PubMed     Abstract available


  355. FARLOW JL, Brenner JC, Lei YL, Chinn SB, et al
    Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.
    Oral Oncol. 2021;120:105420.
    PubMed     Abstract available


  356. STABENAU KA, Akakpo KE, Richmon JD, McMullen C, et al
    Postoperative wound infections in head and neck surgery: The current state of antiseptic and antibiotic practices.
    Oral Oncol. 2021;118:105361.
    PubMed    


  357. DA COSTA REAR, da Silva Junior RG, Magalhaes LAN, Mendes JR, et al
    Locally advanced lymphoepithelial carcinoma of the larynx/hypopharynx: A case report.
    Oral Oncol. 2021;118:105373.
    PubMed     Abstract available


  358. SHARMA D, Rimal J, Kumar Maharjan I, Shrestha A, et al
    Evaluation of oral potentially malignant disorders with autoflorescence, reflectance spectroscopy and vital staining and their correlation with histopathology - Hospital based prospective study.
    Oral Oncol. 2021;118:105312.
    PubMed     Abstract available


  359. PANTA P, Dhopathi SR, Gilligan G, Seshadri M, et al
    Invasive oral squamous cell carcinoma induced by concurrent smokeless tobacco and creamy snuff use: A case report.
    Oral Oncol. 2021;118:105354.
    PubMed     Abstract available


  360. TSAI CY, Lee SR, Lee LY, Hsueh C, et al
    Clinical outcomes of Taiwanese patients with resected squamous cell carcinoma of the upper and lower gum.
    Oral Oncol. 2021;118:105334.
    PubMed     Abstract available


  361. BARRETT TF, Mazul AL, Stepan KO, Wood CB, et al
    The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database.
    Oral Oncol. 2021;118:105330.
    PubMed     Abstract available


  362. DE LIMA-SOUZA RA, Leonel ACLDS, de Almeida OP, de Castro JFL, et al
    Salivary gland cystadenocarcinoma: Rare neoplasm in buccal mucosa.
    Oral Oncol. 2021;118:105314.
    PubMed     Abstract available


  363. DESAI RS, Shirsat PM, Bansal S, Prasad P, et al
    Oral field cancerization: A critical appraisal.
    Oral Oncol. 2021;118:105304.
    PubMed    


  364. JAKHETIYA A, Kaul P, Pandey A, Patel T, et al
    Distribution and determinants of submandibular gland involvement in oral cavity squamous cell carcinoma.
    Oral Oncol. 2021;118:105316.
    PubMed     Abstract available


  365. TURNER MT, Stokes WA, Stokes CM, Hassid S, et al
    Airway and bleeding complications of transoral robotic supraglottic laryngectomy (TORS-SGL): A systematic review and meta-analysis.
    Oral Oncol. 2021;118:105301.
    PubMed    


  366. MCDOWELL L, Gough K, King M, Corry J, et al
    Patient-reported quality of life and symptom burden measures in human papillomavirus associated oropharyngeal cancer - A review of the literature and PRO methodology.
    Oral Oncol. 2021;118:105309.
    PubMed     Abstract available


  367. DHEERAJ K, Kumar R, Pinnaka LB
    6 "I" for endoscopic surgical management of early glottic squamous cell carcinomas.
    Oral Oncol. 2021;118:105308.
    PubMed    


    June 2021
  368. PATEL KB, Mroz EA, Faquin WC, Rocco JW, et al
    A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
    Oral Oncol. 2021;120:105421.
    PubMed     Abstract available


  369. RIBEIRO IP, Lopes T, Pedro N, Barroso L, et al
    Should sitting time be a treatment target in head and neck cancer patients receiving curative treatment?
    Oral Oncol. 2021 Jun 26:105418. doi: 10.1016/j.oraloncology.2021.105418.
    PubMed    


  370. DAHLSTROM KR, Anderson KS, Guo M, Kwon MC, et al
    Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial.
    Oral Oncol. 2021;120:105397.
    PubMed     Abstract available


  371. YANG J, Wan SQ, Huang L, Zhong WJ, et al
    Analysis of hospitalization costs and length of stay for oral cancer patients undergoing surgery: Evidence from Hunan, China.
    Oral Oncol. 2021;119:105363.
    PubMed     Abstract available


  372. AMBRE S, Sultania M, Biswal S, Mitra S, et al
    Poorly differentiated "insular" thyroid carcinoma with solitary vascular mandibular metastasis - A rare histology and management.
    Oral Oncol. 2021 Jun 24:105416. doi: 10.1016/j.oraloncology.2021.105416.
    PubMed    


  373. ZHU MY, Wu HJ, Miao JJ, Di MP, et al
    Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose.
    Oral Oncol. 2021;120:105378.
    PubMed     Abstract available


  374. LENZE NR, Farquhar DR, Sheth S, Zevallos JP, et al
    Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma.
    Oral Oncol. 2021;119:105377.
    PubMed     Abstract available


  375. LIEN MY, Wang TH, Hsieh CY, Tsai MH, et al
    Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival.
    Oral Oncol. 2021;119:105380.
    PubMed     Abstract available


  376. KAVARTHAPU A, Gurumoorthy K
    Linking chronic periodontitis and oral cancer: A review.
    Oral Oncol. 2021 Jun 14:105375. doi: 10.1016/j.oraloncology.2021.105375.
    PubMed     Abstract available


  377. MA C, Sheng S, Shen Y, Gao W, et al
    A comparative study on using superior thyroid artery perforator flaps versus traditional sternocleidomastoid myocutaneous flaps for reconstructions after oral cancer ablation: "New tricks for old dogs"?
    Oral Oncol. 2021 Jun 11:105374. doi: 10.1016/j.oraloncology.2021.105374.
    PubMed     Abstract available


  378. BRAS L, de Vries J, Festen S, Steenbakkers RJHM, et al
    Frailty and restrictions in geriatric domains are associated with surgical complications but not with radiation-induced acute toxicity in head and neck cancer patients: A prospective study.
    Oral Oncol. 2021;118:105329.
    PubMed     Abstract available


  379. KARABAJAKIAN A, Bouaoud J, Michon L, Kamal M, et al
    Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity.
    Oral Oncol. 2021;119:105368.
    PubMed     Abstract available


  380. XU J, Wang R, Wang T, Wang T, et al
    Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
    Oral Oncol. 2021;119:105369.
    PubMed     Abstract available


  381. ALVES LDB, de Melo AC, de Lima Araujo LH, Thiago LS, et al
    Secretory carcinoma of salivary glands at the National Cancer Institute: A 20-year retrospective clinical, pathological, immunohistochemical and molecular study.
    Oral Oncol. 2021;117:105198.
    PubMed     Abstract available


  382. VARGHESE BT, Divya GM, Janardhan D, Thomas S, et al
    Is there a role for HRCT in head and neck surgical oncology work up during the COVID pandemic?
    Oral Oncol. 2021;117:105194.
    PubMed    


  383. JIANG WN, Olson R
    Transoral surgery may be less cost effective than radiotherapy: In response to: Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-medicare analysis.
    Oral Oncol. 2021;117:105178.
    PubMed    


  384. PARIKH AS, Kang SY
    Variation in elective treatment of the contralateral neck in oropharyngeal cancer.
    Oral Oncol. 2021;117:105186.
    PubMed    


  385. SARODE GS, Sarode SC, Sengupta N, Sharma NK, et al
    Readdressing dysplasia at surgical margins as predictive biomarker of malignant transformation.
    Oral Oncol. 2021;117:105181.
    PubMed     Abstract available


  386. COMBES JD, Voisin N, Perie S, Malard O, et al
    History of tonsillectomy and risk of oropharyngeal cancer.
    Oral Oncol. 2021;117:105302.
    PubMed     Abstract available


  387. PATEL MR, Ottenstein L, Ryan M, Farrell A, et al
    TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORS.
    Oral Oncol. 2021;117:105294.
    PubMed     Abstract available


  388. HEFT NEAL ME, Gensterblum-Miller E, Bhangale AD, Kulkarni A, et al
    Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma.
    Oral Oncol. 2021;117:105270.
    PubMed     Abstract available


  389. BURASSAKARN A, Srisathaporn S, Pientong C, Wongjampa W, et al
    Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-alpha pathway.
    Oral Oncol. 2021;117:105279.
    PubMed     Abstract available


    May 2021
  390. TECKIE S, Wotman M, Marziliano A, Orner D, et al
    Patterns of alcohol use among early head and neck cancer survivors: A cross-sectional survey study using the alcohol use disorders identification test (AUDIT).
    Oral Oncol. 2021;119:105328.
    PubMed     Abstract available


  391. DE FELICE F, Lei M, Oakley R, Lyons A, et al
    Risk stratified follow up for head and neck cancer patients - An evidence based proposal.
    Oral Oncol. 2021;119:105365.
    PubMed     Abstract available


  392. LIN MC, Leu YS, Chiang CJ, Ko JY, et al
    Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis.
    Oral Oncol. 2021;119:105358.
    PubMed     Abstract available


  393. PENG Y, Xiao L, Rong H, Ou Z, et al
    Single-cell profiling of tumor-infiltrating TCF1/TCF7(+) T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer.
    Oral Oncol. 2021;119:105348.
    PubMed     Abstract available


  394. COSTANTINO A, De Virgilio A, Spriano G
    Is the current oropharyngeal cancer T classification adequate in the era of HPV and transoral robotic surgery?
    Oral Oncol. 2021 May 25:105359. doi: 10.1016/j.oraloncology.2021.105359.
    PubMed    


  395. DESIDERI I, Becherini C, Belgioia L, Merlotti A, et al
    Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review.
    Oral Oncol. 2021;119:105355.
    PubMed     Abstract available


  396. BERZENJI D, Sewnaik A, Keereweer S, Monserez DA, et al
    Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2021;119:105356.
    PubMed     Abstract available


  397. SCHOONBEEK RC, Bult FFS, Plaat BEC, Witjes MJH, et al
    Incidental findings during the diagnostic work-up in the head and neck cancer pathway: Effects on treatment delay and survival.
    Oral Oncol. 2021;118:105350.
    PubMed     Abstract available


  398. CHEN X, Li Y, Li X, Cao X, et al
    An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features.
    Oral Oncol. 2021;118:105335.
    PubMed     Abstract available


  399. PATTERSON JM, Lu L, Watson LJ, Harding S, et al
    Trends in, and predictors of, swallowing and social eating outcomes in head and neck cancer survivors: A longitudinal analysis of head and neck 5000.
    Oral Oncol. 2021;118:105344.
    PubMed     Abstract available


  400. AL-QURAYSHI Z, Randolph GW, Kandil E
    Cost-effectiveness of computed tomography nodal scan in patients with papillary thyroid carcinoma.
    Oral Oncol. 2021;118:105326.
    PubMed     Abstract available


  401. VENTURA TMO, Santos PSS, Ribeiro NR, de Lima Leite A, et al
    Is there difference in the comparative and quantitative salivary proteome between stimulated and unstimulated saliva in head and neck cancer patients treated by radiotherapy?
    Oral Oncol. 2021 May 10:105315. doi: 10.1016/j.oraloncology.2021.105315.
    PubMed     Abstract available


  402. ZHOU L
    Concerns about human papillomavirus-associated oropharyngeal cancer detection methods.
    Oral Oncol. 2021;116:105143.
    PubMed    


  403. THADURI A, Bansal A, Anthony ML, Narayan ML, et al
    Brown tumor, parathyroid adenoma, and papillary thyroid cancer: A triple whammy.
    Oral Oncol. 2021;116:105159.
    PubMed    


  404. DOUMAS S, Koursoumi R, Dhanda J, Surwald C, et al
    Minimaly invasive benign parotid surgery in selected patients: An adaptation example to compensate for COVID19 backlog or new era?
    Oral Oncol. 2021;116:105170.
    PubMed    


  405. NGUYEN A, Nagasaka M
    Forget me not - Incorporating standard chemotherapy in an exciting era of clinical trials.
    Oral Oncol. 2021;116:105160.
    PubMed     Abstract available


  406. RODRIGUES-FERNANDES CI, Arboleda LPA, Vargas PA, Lopes MA, et al
    Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia.
    Oral Oncol. 2021;116:105144.
    PubMed     Abstract available


  407. HAIST C, Schulte E, Bartels N, Bister A, et al
    CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells.
    Oral Oncol. 2021;116:105259.
    PubMed     Abstract available


  408. DE KONING KJ, Koppes SA, de Bree R, Dankbaar JW, et al
    Feasibility study of ultrasound-guided resection of tongue cancer with immediate specimen examination to improve margin control - Comparison with conventional treatment.
    Oral Oncol. 2021;116:105249.
    PubMed     Abstract available


  409. SAKTHIVEL P, Raveendran S, Panda S, Singh CA, et al
    Oral potential malignant disorders - A long list not to be forgotten.
    Oral Oncol. 2021;116:105244.
    PubMed    


  410. HERREROS-POMARES A, Llorens C, Soriano B, Bagan L, et al
    Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
    Oral Oncol. 2021;116:105191.
    PubMed     Abstract available


  411. LI R, Wang Q, Yan L, Zhu Y, et al
    Radiotherapy versus partial laryngectomy in the management of early glottic cancer with anterior commissure involvement: A propensity score matched study with 256 patients.
    Oral Oncol. 2021;116:105230.
    PubMed     Abstract available


  412. NEWMAN M, Dziegielewski PT, Nguyen NTA, Seikaly HS, et al
    Relationship of depth of invasion to survival outcomes and patterns of recurrence for T3 oral tongue squamous cell carcinoma.
    Oral Oncol. 2021;116:105195.
    PubMed     Abstract available


  413. OH LJ, Asher R, Veness M, Smee R, et al
    Effect of age and gender in non-smokers with oral squamous cell carcinoma: Multi-institutional study.
    Oral Oncol. 2021;116:105210.
    PubMed     Abstract available


  414. BAREM RABENHORST SH, Lima Verde Osterne R, Weege Nonaka CF, Montezuma Sales Rodrigues A, et al
    Detection of deletions in 1q25, 1p36 and 1pTEL and chromosome 17 aneuploidy in oral epithelial dysplasia and oral squamous cell carcinoma by fluorescence in situ hybridization (FISH).
    Oral Oncol. 2021;116:105221.
    PubMed     Abstract available


    April 2021
  415. DA SILVA LEONEL ACL, Ribeiro ILA, de Souza MLM, Kaminagakura E, et al
    COVID-19, changes in smoking behaviour, and head and neck cancer: Current data and future perspectives.
    Oral Oncol. 2021 Apr 30:105327. doi: 10.1016/j.oraloncology.2021.105327.
    PubMed    


  416. ZONG J, Liu Y, Liang Q, Xu H, et al
    Administration of oral maintenance chemotherapy for 1 year following definitive chemoradiotherapy may improve the survival of patients with stage N3 nasopharyngeal carcinoma.
    Oral Oncol. 2021;118:105313.
    PubMed     Abstract available


  417. SINHA NK, Kohli PS, Nagarajan K, Gochhait D, et al
    A nomogram for predicting the risk of neck node metastasis in oral cavity carcinoma using acoustic radiation force impulse imaging (ARFI).
    Oral Oncol. 2021;118:105311.
    PubMed     Abstract available


  418. YVER CM, Shimunov D, Weinstein GS, Rajasekaran K, et al
    Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery.
    Oral Oncol. 2021;118:105307.
    PubMed     Abstract available


  419. LYNCH PT, Horani S, Lee R, Sumer BD, et al
    Effectiveness of physical activity interventions in improving objective and patient-reported outcomes in head and neck cancer survivors: A systematic review.
    Oral Oncol. 2021;117:105253.
    PubMed     Abstract available


  420. VALLINA C, Lopez-Pintor RM, Gonzalez-Serrano J, de Vicente JC, et al
    Genes involved in the epithelial-mesenchymal transition in oral cancer: A systematic review.
    Oral Oncol. 2021;117:105310.
    PubMed     Abstract available


  421. RAJASEKARAN K, Carey RM, Lin X, Seckar TD, et al
    The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis.
    Oral Oncol. 2021;117:105305.
    PubMed     Abstract available


  422. KREINBRINK PJ, Li J, Parajuli S, Wise-Draper TM, et al
    Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2021;116:105245.
    PubMed     Abstract available


  423. DHAKAL R, Moeller BJ, Prabhu RS, Frenkel CH, et al
    Pattern of distant metastasis in oropharyngeal carcinoma - Do they differ by HPV status?
    Oral Oncol. 2021 Apr 18:105286. doi: 10.1016/j.oraloncology.2021.105286.
    PubMed    


  424. FANNY C, Sebastien L, Pascale G, Antoine N, et al
    Physician practice variation in head and neck cancer therapy: Results of a national survey.
    Oral Oncol. 2021;117:105293.
    PubMed     Abstract available


  425. MOUTAFI M, Economopoulou P, Rimm D, Psyrri A, et al
    PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data.
    Oral Oncol. 2021;117:105292.
    PubMed     Abstract available


  426. XIANG ZF, Hu DF, Xiong HC, Li MY, et al
    Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database.
    Oral Oncol. 2021;117:105284.
    PubMed     Abstract available


  427. KUMAR R, Dheeraj K
    Do ipsilateral lateralized squamous cell carcinomas of oral tongue with a depth of invasion (DOI) greater than 10 mm warrant a bilateral neck dissection to prevent future regional recurrences on contralateral side? A continuing conundrum.
    Oral Oncol. 2021 Apr 7:105285. doi: 10.1016/j.oraloncology.2021.105285.
    PubMed    


  428. SCHREIBER A, Mattavelli D, Accorona R, Rampinelli V, et al
    Endoscopic-assisted multi-portal compartmental resection of the masticatory space in oral cancer: Anatomical study and preliminary clinical experience.
    Oral Oncol. 2021;117:105269.
    PubMed     Abstract available


  429. RAUSO R, Chirico F, Federico F, Francesco Nicoletti G, et al
    Maxillo-facial reconstruction following cancer ablation during COVID-19 pandemic in southern Italy.
    Oral Oncol. 2021;115:105114.
    PubMed     Abstract available


  430. SAKTHIVEL P, Raveendran S, Panda S, Singh CA, et al
    Synchronous primary neoplasia in patients with p16 positive oropharyngeal carcinoma: Does the 2nd cancer really matters?
    Oral Oncol. 2021;115:105113.
    PubMed    


  431. PARAG-SHARMA K, Tasoulas J, Musicant AM, do Nascimento-Filho CHV, et al
    Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.
    Oral Oncol. 2021;115:105166.
    PubMed     Abstract available


  432. LIU HY, Tam L, Woody NM, Caudell J, et al
    Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study.
    Oral Oncol. 2021;115:105190.
    PubMed     Abstract available


  433. LORINI L, Ardighieri L, Bozzola A, Romani C, et al
    Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma.
    Oral Oncol. 2021;115:105213.
    PubMed     Abstract available


  434. PRICE JM, West CM, Mistry HB, Betts G, et al
    Improved survival prediction for oropharyngeal cancer beyond TNMv8.
    Oral Oncol. 2021;115:105140.
    PubMed     Abstract available


  435. TRETIAKOW D, Mollin E, Stodulski D
    Metastasis of the testicular germ cell tumors to the parotid gland.
    Oral Oncol. 2021;115:105132.
    PubMed    


  436. LOMBARDI N, Varoni EM, Moneghini L, Lodi G, et al
    Submucosal oral squamous cell carcinoma of the tongue.
    Oral Oncol. 2021;115:105121.
    PubMed    


  437. GANCI F, Allegretti M, Manciocco V, Fiorentino F, et al
    Two distinct TP53 mutations in HNSCC primary tumor: Only one circulates in the blood.
    Oral Oncol. 2021;115:105096.
    PubMed    


  438. HUANG NS, Cao YM, Lu ZW, Guan Q, et al
    Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
    Oral Oncol. 2021;115:105092.
    PubMed     Abstract available


    March 2021
  439. SWAIN M, Ghosh-Laskar S
    Stereotactic body radiotherapy (SBRT) for primary non-metastatic head and neck cancer: When less is enough.
    Oral Oncol. 2021;116:105265.
    PubMed     Abstract available


  440. IQBAL MS, Morgan D, West N, Paterson C, et al
    Hypofractionated chemoradiation (2.75 Gy per fraction) in Head and Neck Cancer: Extreme caution required.
    Oral Oncol. 2021 Mar 21:105261. doi: 10.1016/j.oraloncology.2021.105261.
    PubMed    


  441. CAO C, Gan X, He Y, Su Y, et al
    Diagnostic efficacy of PET-CT, CT, and MRI in preoperative assessment of mandibular invasion caused by head and neck cancer: A systematic review and meta-analysis.
    Oral Oncol. 2021;116:105264.
    PubMed     Abstract available


  442. PUCCI R, Cassoni A, Battisti A, Valentini V, et al
    Covid-19 pandemic and head and neck cancers, what should we expect?
    Oral Oncol. 2021 Mar 15:105263. doi: 10.1016/j.oraloncology.2021.105263.
    PubMed    


  443. TANI R, Ito N, Matsui K, Yamasaki S, et al
    MICA A5.1 homozygous genotype is associated with a risk for early-onset oral cancer.
    Oral Oncol. 2021;116:105256.
    PubMed     Abstract available


  444. DIANA G, Corica C
    Human Papilloma Virus vaccine and prevention of head and neck cancer, what is the current evidence?
    Oral Oncol. 2021;115:105168.
    PubMed     Abstract available


  445. KIM HAJ, Zeng PYF, Shaikh MH, Mundi N, et al
    All HPV-negative head and neck cancers are not the same: Analysis of the TCGA dataset reveals that anatomical sites have distinct mutation, transcriptome, hypoxia, and tumor microenvironment profiles.
    Oral Oncol. 2021;116:105260.
    PubMed     Abstract available


  446. ILHAN B, Guneri P, Wilder-Smith P
    The contribution of artificial intelligence to reducing the diagnostic delay in oral cancer.
    Oral Oncol. 2021;116:105254.
    PubMed     Abstract available


  447. MO Y, Zhang B, Pan Y, Qin Q, et al
    Impact of the weekday of the first intensity-modulated radiotherapy treatment on the survival outcomes of patients with nasopharyngeal carcinoma: A multicenter cohort study.
    Oral Oncol. 2021;116:105258.
    PubMed     Abstract available


  448. LAN R, Catherine JH, Chossegros C, Campana F, et al
    Temporal association between the introduction of public health programs and interest in oral cancers on the internet in the European Union.
    Oral Oncol. 2021 Mar 5:105250. doi: 10.1016/j.oraloncology.2021.105250.
    PubMed    


  449. HANDE A, Sonone A, Gadbail A, Gawande M, et al
    Modalities to restrain the progression of oral potentially malignant diseases and oral squamous cell carcinoma in COVID-19 pandemic.
    Oral Oncol. 2021;114:105072.
    PubMed    


  450. CHUMPITAZ-CERRATE V, Chavez-Rimache L, Rodriguez-Flores A
    Challenges in the early diagnosis of oral cancer in rural populations in Peru during the COVID-19 pandemic.
    Oral Oncol. 2021 Mar 1:105251. doi: 10.1016/j.oraloncology.2021.105251.
    PubMed    


  451. DESAI RS, Shirsat PM, Bansal S, Prasad P, et al
    Comment on "Malignant transformation evidences of Oral Lichen Planus: When the time is of the essence" by Zotti F et al (May 2020).
    Oral Oncol. 2021;114:105080.
    PubMed    


  452. DE ALMEIDA JR, Seungyeon Kim V, O'Sullivan B, Goldstein DP, et al
    Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey.
    Oral Oncol. 2021;114:105165.
    PubMed     Abstract available


  453. FERRARI M, Migliorati S, Tomasoni M, Crisafulli V, et al
    Sinonasal cancer encroaching the orbit: Ablation or preservation?
    Oral Oncol. 2021;114:105185.
    PubMed     Abstract available


  454. YANG K, Ahn YC, Nam H, Hong SD, et al
    Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients.
    Oral Oncol. 2021;114:105180.
    PubMed     Abstract available


  455. HENG Y, Zhang D, Zhou L, Zhang M, et al
    Assessment and treatment strategies for occult contralateral lymph node metastasis in hypopharyngeal squamous cell carcinoma patients with ipsilateral node-positive necks.
    Oral Oncol. 2021;114:105183.
    PubMed     Abstract available


  456. BENOIT C, Orbach D, Cyrille S, Belhous K, et al
    Head and neck tumors in children and adolescents: Impact of a multidisciplinary tumor board.
    Oral Oncol. 2021;114:105145.
    PubMed     Abstract available


  457. CUI J, Wang D, Nie D, Liu W, et al
    Difference in tumor mutation burden between squamous cell carcinoma in the oral cavity and larynx.
    Oral Oncol. 2021;114:105142.
    PubMed     Abstract available


  458. OPPELT P, Ley JC, Worden F, Palka K, et al
    Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial.
    Oral Oncol. 2021;114:105164.
    PubMed     Abstract available


  459. LIN NC, Su IH, Hsu JT, Chang YJ, et al
    Comparison of different lymph node staging systems in patients with positive lymph nodes in oral squamous cell carcinoma.
    Oral Oncol. 2021;114:105146.
    PubMed     Abstract available


  460. LEE NCJ, Eskander A, Miccio JA, Park HS, et al
    Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping system.
    Oral Oncol. 2021;114:105137.
    PubMed     Abstract available


  461. GOOSMANN M, Chang S, Craig J
    Treating sinonasal crusting and infection after palatal and sinonasal cancer resection with topical antibiotic irrigations.
    Oral Oncol. 2021;114:105077.
    PubMed    


  462. ERKUL E, Yilmaz I
    TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
    Oral Oncol. 2021;114:105089.
    PubMed     Abstract available


  463. GOMES N, Huynh A, Borel C, Guenounou S, et al
    Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohort.
    Oral Oncol. 2021;114:105082.
    PubMed     Abstract available


  464. LEITE AK, Kulcsar MAV, Matsuura D, Matos LL, et al
    Amelanotic melanoma presenting as a tongue tumor.
    Oral Oncol. 2021;114:105075.
    PubMed    


  465. SINGHAVI HR, Khare N, Singh A, Khandelwal A, et al
    Impact of pre-operative serum C-reactive protein and cell-free chromatin levels on tumor aggressiveness and survival outcome in oral cavity squamous cell carcinoma.
    Oral Oncol. 2021;114:105078.
    PubMed     Abstract available


  466. DHARA V, Kudva A, Chithra A, Rajan J, et al
    Reconstruction of buccal mucosa: A minimalist symbiotic approach with local flaps.
    Oral Oncol. 2021;114:105081.
    PubMed     Abstract available


    February 2021
  467. AWAN MJ, Gittleman H, Barnholtz-Sloan J, Machtay M, et al
    Risk groups of laryngeal cancer treated with chemoradiation according to nomogram scores - A pooled analysis of RTOG 0129 and 0522.
    Oral Oncol. 2021;116:105241.
    PubMed     Abstract available


  468. FREIHAT O, Toth Z, Pinter T, Kedves A, et al
    Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC).
    Oral Oncol. 2021;116:105239.
    PubMed     Abstract available


  469. DEVARAJA K
    Erratum to "The surgical sequence of neck dissection and primary tumor excision could impact the locoregional recurrence rates in oral squamous cell carcinoma" [Oral Oncol. 110 (2020) 104809].
    Oral Oncol. 2021 Feb 24:105229. doi: 10.1016/j.oraloncology.2021.105229.
    PubMed    


  470. ZSCHAECK S, Weingartner J, Ghadjar P, Wust P, et al
    Fever range whole body hyperthermia for re-irradiation of head and neck squamous cell carcinomas: Final results of a prospective study.
    Oral Oncol. 2021;116:105240.
    PubMed     Abstract available


  471. LIN M, Yang Q, You R, Zou X, et al
    Metastatic characteristics associated with survival of synchronous metastatic nasopharyngeal carcinoma in non-epidemic areas.
    Oral Oncol. 2021;115:105200.
    PubMed     Abstract available


  472. NORTH LM, Harvey E, Vanle B, Shreenivas A, et al
    Frequent omission of radiation after flap reconstruction of head and neck cancer: Are we dooming patients to failure?
    Oral Oncol. 2021 Feb 18:105225. doi: 10.1016/j.oraloncology.2021.105225.
    PubMed    


  473. HUANG L, Zhang X, Bai Y, Chua KLM, et al
    Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study.
    Oral Oncol. 2021;115:105222.
    PubMed     Abstract available


  474. FADEN DL, O'Boyle CJ, Lin DT, Deschler DG, et al
    Prospective assessment of multiple HPV-positive oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2021 Feb 15:105212. doi: 10.1016/j.oraloncology.2021.105212.
    PubMed    


  475. SANTOSO AMM, Jansen F, Lissenberg-Witte BI, Baatenburg de Jong RJ, et al
    Sleep quality trajectories from head and neck cancer diagnosis to six months after treatment.
    Oral Oncol. 2021;115:105211.
    PubMed     Abstract available


  476. LEON X, Orus C, Casasayas M, Neumann E, et al
    Trends in disease-specific survival of head and neck squamous cell carcinoma patients treated in a single institution over a 30-year period.
    Oral Oncol. 2021;115:105184.
    PubMed     Abstract available


  477. GALLO O, Locatello LG
    All that glitters is not gold: Clinical implications from the genetic analysis of head and neck cancer recurrences.
    Oral Oncol. 2021 Feb 10:105187. doi: 10.1016/j.oraloncology.2021.105187.
    PubMed    


  478. MA SJ, Iovoli AJ, Attwood K, Wooten KE, et al
    Association of significant financial burden with survival for head and neck cancer patients treated with radiation therapy.
    Oral Oncol. 2021;115:105196.
    PubMed     Abstract available


  479. ADKINS DR, Lin JC, Sacco A, Ley J, et al
    Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naive, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial.
    Oral Oncol. 2021;115:105192.
    PubMed     Abstract available


  480. MENEZES FDS, Fernandes GA, Antunes JLF, Villa LL, et al
    Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies.
    Oral Oncol. 2021;115:105177.
    PubMed     Abstract available


  481. VIGANO A, De Felice F, Iacovelli NA, Alterio D, et al
    M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy +/- systemic therapy - A study of the Italian Association of Radiotherapy and Clin
    Oral Oncol. 2021;115:105189.
    PubMed     Abstract available


  482. OH LJ, Satgunaseelan L, Asher R, Veness M, et al
    Young age is not a predictor of disease specific survival in oral cancer: A multi-institutional study.
    Oral Oncol. 2021;115:105162.
    PubMed     Abstract available


  483. ADKINS D, Ley J, Atiq O, Powell S, et al
    Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial.
    Oral Oncol. 2021;115:105173.
    PubMed     Abstract available


  484. VREUGDENHIL M, Fong C, Sanghera P, Hartley A, et al
    Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial.
    Oral Oncol. 2021;113:105112.
    PubMed     Abstract available


  485. SENGUPTA N, Sarode GS, Sarode SC, Gadbail AR, et al
    Optimum surgical margins in squamous cell carcinoma of the oral tongue: Does shrinkage matters?
    Oral Oncol. 2021;113:105052.
    PubMed    


  486. GONZALEZ-MOLES MA, Warnakulasuriya S, Gonzalez-Ruiz I, Gonzalez-Ruiz L, et al
    Clinical interpretation of findings from a systematic review and a comprehensive meta-analysis on clinicopathological and prognostic characteristics of oral squamous cell carcinomas (OSCC) arising in patients with oral lichen planus (OLP): Author's re
    Oral Oncol. 2021;113:105036.
    PubMed    


  487. TRETIAKOW D, Stodulski D, Mikaszewski B
    Regarding the "Tumour spillage of the pleomorphic adenoma of the parotid gland: A proposal for intraoperative measures".
    Oral Oncol. 2021;113:105026.
    PubMed    


  488. LEE SJ, Kim YS, Kay CS, Kim M, et al
    The effect of adjuvant chemotherapy and early tumor regression on the outcome of nasopharyngeal cancer patients treated with concurrent chemoradiotherapy.
    Oral Oncol. 2021;113:105130.
    PubMed     Abstract available


  489. MATSUYAMA R, Maeda K, Yamanaka Y, Ishida Y, et al
    Assessing skeletal muscle mass based on the cross-sectional area of muscles at the 12th thoracic vertebra level on computed tomography in patients with oral squamous cell carcinoma.
    Oral Oncol. 2021;113:105126.
    PubMed     Abstract available


  490. CARNEVALE C, Ortiz-Gonzalez I, Ortiz-Gonzalez A, Bodi-Blanes L, et al
    Early T1-T2 stage p16+ oropharyngeal tumours. Role of upfront transoral robotic surgery in de-escalation treatment strategies. A review of the current literature.
    Oral Oncol. 2021;113:105111.
    PubMed     Abstract available


  491. ROY P, Mallick I, Arun I, Zameer L, et al
    Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection.
    Oral Oncol. 2021;113:105115.
    PubMed     Abstract available


  492. ADDERLEY H, Rack S, Hapuarachi B, Feeney L, et al
    The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma.
    Oral Oncol. 2021;113:105095.
    PubMed     Abstract available


  493. KERAWALA CJ, Riva F, Paleri V
    The impact of early oral feeding following head and neck free flap reconstruction on complications and length of stay.
    Oral Oncol. 2021;113:105094.
    PubMed     Abstract available


  494. SAKTHIVEL P, Panda S, Singh CA, Rajeshwari M, et al
    T4a in 8th AJCC tongue cancers - A non-existent entity in surgical practice!
    Oral Oncol. 2021;113:105051.
    PubMed    


  495. HEFT NEAL ME, Gao RW, Brennan JR, Haring CT, et al
    Functional outcomes and tracheostomy dependence following salvage oropharyngeal surgery.
    Oral Oncol. 2021;113:105034.
    PubMed    


  496. TERENZI V, Battisti A, Della Monaca M, Priore P, et al
    Management of a rare case of squamous cell carcinoma of the tongue in a patient affected by progeria.
    Oral Oncol. 2021;113:105032.
    PubMed    


    January 2021
  497. THADURI A, Chadha L, Poonia DR, Rajkumar KS, et al
    Oral cancer screening - A delphic horizon in India.
    Oral Oncol. 2021 Jan 26:105174. doi: 10.1016/j.oraloncology.2020.105174.
    PubMed    


  498. MA HH, Chen DS, Li S, Xiao MZ, et al
    The value and inadequacy of tumor mutation burden on efficacy of immune checkpoint inhibitors in head and neck cancers.
    Oral Oncol. 2021 Jan 26:105179. doi: 10.1016/j.oraloncology.2021.105179.
    PubMed    


  499. JELINEK MJ, Foster NR, Zoroufy AJ, Schwartz GK, et al
    A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101.
    Oral Oncol. 2021;114:105171.
    PubMed     Abstract available


  500. CHAN SK, Chan SY, Tong CC, Lam KO, et al
    Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carc
    Oral Oncol. 2021;114:105158.
    PubMed     Abstract available


  501. PILAR A, Yu E, Su J, O'Sullivan B, et al
    Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma.
    Oral Oncol. 2021;114:105167.
    PubMed     Abstract available


  502. YILMAZ E, Ozbun MA, Gan GN
    Molecular and immune signature of HPV-positive oral cavity squamous cell carcinoma.
    Oral Oncol. 2021 Jan 25:105175. doi: 10.1016/j.oraloncology.2020.105175.
    PubMed    


  503. HOWLETT J, Hamilton S, Ye A, Jewett D, et al
    Treatment and outcomes of nasopharyngeal carcinoma in a unique non-endemic population.
    Oral Oncol. 2021;114:105182.
    PubMed     Abstract available


  504. DEVARAJA K
    De-escalation of aggressive adjuvant therapy for limited extranodal extension in head and neck cancer.
    Oral Oncol. 2021 Jan 18:105161. doi: 10.1016/j.oraloncology.2020.105161.
    PubMed    


  505. MARTELLI AJ, Machado RA, Pereira WM, Silveira DMM, et al
    Impact of the COVID-19 pandemic in the head and neck cancer treatment in the Brazil.
    Oral Oncol. 2021 Jan 18:105148. doi: 10.1016/j.oraloncology.2020.105148.
    PubMed    


  506. BHATTASALI O, Torres FA, Kang HK, Thompson LDR, et al
    Prognostic impact of retropharyngeal lymphadenopathy in early-stage HPV-associated oropharyngeal cancer: Implications for staging optimization.
    Oral Oncol. 2021;114:105147.
    PubMed    


  507. VARELA-CENTELLES P, Seoane J, Bilbao A, Seoane-Romero J, et al
    Covid-19 pandemic: A new contributing factor to diagnostic and treatment delay in oral cancer patients.
    Oral Oncol. 2021 Jan 15:105176. doi: 10.1016/j.oraloncology.2020.105176.
    PubMed    


  508. JOHNSON D, Ma BBY
    Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma.
    Oral Oncol. 2021;113:105127.
    PubMed     Abstract available


  509. TREVISIOL C, Gion M, Vaona A, Fabricio ASC, et al
    The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluation.
    Oral Oncol. 2021;114:105128.
    PubMed     Abstract available


  510. EMMETT SE, Stark MS, Pandeya N, Panizza B, et al
    MicroRNA expression is associated with human papillomavirus status and prognosis in mucosal head and neck squamous cell carcinomas.
    Oral Oncol. 2021;113:105136.
    PubMed     Abstract available


  511. MCCARTHY CE, Fedele S, Ho M, Shaw R, et al
    UK consensus recommendations on the management of oral epithelial dysplasia during COVID-19 pandemic outbreaks.
    Oral Oncol. 2021;112:105110.
    PubMed     Abstract available


  512. BURTNESS B, Ge J
    Reply to "Keynote 48: Is it really for everyone?"
    Oral Oncol. 2021;112:104983.
    PubMed    


  513. YOUSSEF MR, Reisner ASC, Attia AS, Hussein MH, et al
    Obesity and the prevention of thyroid cancer: Impact of body mass index and weight change on developing thyroid cancer - Pooled results of 24 million cohorts.
    Oral Oncol. 2021;112:105085.
    PubMed     Abstract available


  514. SHER DJ, Yan J, Day AT, Khan S, et al
    Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-Medicare analysis.
    Oral Oncol. 2021;112:105029.
    PubMed     Abstract available


  515. WANG D, Lu Y, Nannapaneni S, Griffith CC, et al
    Combinatorial approaches targeting the EGFR family and c-Met in SCCHN.
    Oral Oncol. 2021;112:105074.
    PubMed     Abstract available


  516. LOMBARDI D, Tomasoni M, Paderno A, Mattavelli D, et al
    The impact of nodal status in major salivary gland carcinoma: A multicenter experience and proposal of a novel N-classification.
    Oral Oncol. 2021;112:105076.
    PubMed     Abstract available


  517. WINDON MJ, Le D, D'Souza G, Bigelow E, et al
    Treatment decision-making among patients with oropharyngeal squamous cell cancer: A qualitative study.
    Oral Oncol. 2021;112:105044.
    PubMed     Abstract available


  518. ALVES A, Diel L, Ramos G, Pinto A, et al
    Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
    Oral Oncol. 2021;112:105038.
    PubMed     Abstract available


  519. BARROS DE OLIVEIRA A, Morandin Ferrisse T, Albergoni Silveira H, Vilela Silva E, et al
    Intraoral atypical lentiginous melanocytic lesion in a pediatric patient.
    Oral Oncol. 2021;112:105017.
    PubMed     Abstract available


  520. NOGAL P, Bartkowiak E, Iwanik K, Wierzbicka M, et al
    Common sense and tumor treatment. A case of pilomatrical carcinoma in a 21-year-old patient with surprisingly rapid tumor progression.
    Oral Oncol. 2021;112:105007.
    PubMed     Abstract available


  521. FLUKES S, Lohia S, Barker CA, Cracchiolo JR, et al
    Are our patients doing better? A single institution experience of an evolving management paradigm for sinonasal mucosal melanoma.
    Oral Oncol. 2021;112:105006.
    PubMed    


  522. BHORIWAL S, Sharma J, Dhall K, Mandal A, et al
    Duplication of the internal jugular vein - A rare anatomical variation.
    Oral Oncol. 2021;112:104985.
    PubMed    


  523. MANTSOPOULOS K, Iro H
    Tumour spillage of the pleomorphic adenoma of the parotid gland: A proposal for intraoperative measures.
    Oral Oncol. 2021;112:104986.
    PubMed     Abstract available


    December 2020
  524. LORINI L, Merlano M, Licitra L, Ravanelli M, et al
    Brain metastasis in head and neck squamous cell carcinoma after immune check point inhibitors treatment.
    Oral Oncol. 2020 Dec 31:105138. doi: 10.1016/j.oraloncology.2020.105138.
    PubMed    


  525. VIPPARTHI K, Patel AK, Ghosh S, Das S, et al
    Two novel cell culture models of buccal mucosal oral cancer from patients with no risk-habits of tobacco smoking or chewing.
    Oral Oncol. 2020;113:105131.
    PubMed     Abstract available


  526. PELLINI R, Campo F, Sergi D, Cappuzzo F, et al
    Role of Pembrolizumab in recurrent or metastatic head and neck carcinoma.
    Oral Oncol. 2020 Dec 29:105133. doi: 10.1016/j.oraloncology.2020.105133.
    PubMed    


  527. ALMANGUSH A, Makitie AA, Leivo I
    Back to basics: Hematoxylin and eosin staining is the principal tool for histopathological risk assessment of oral cancer.
    Oral Oncol. 2020 Dec 29:105134. doi: 10.1016/j.oraloncology.2020.105134.
    PubMed    


  528. MATSUO M, Yasumatsu R, Masuda M, Toh S, et al
    Drug-induced interstitial lung disease in recurrent and/or metastatic head and neck cancer patients treated with cetuximab and/or nivolumab.
    Oral Oncol. 2020;113:105129.
    PubMed     Abstract available


  529. CHRISTOPHERSON KM, Moreno AC, Elgohari B, Gross N, et al
    Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.
    Oral Oncol. 2020;113:105125.
    PubMed     Abstract available


  530. SUBRAMANIAM N, Clark JR, Goldstein D, de Almeida J, et al
    Geographical heterogeneity in the American Joint committee on Cancer oral cancer staging and prognostic implications.
    Oral Oncol. 2020;113:105122.
    PubMed     Abstract available


  531. NOEL CW, Sutradhar R, Li Q, Forner D, et al
    Chinese and South Asian ethnicity, immigration status and head and neck cancer outcomes: A population based study.
    Oral Oncol. 2020;113:105118.
    PubMed     Abstract available


  532. MERCHANT YP, Subash A, Shetty S, George A, et al
    A relook at how we assess tumor margins: Is it 'TIME' for new criteria?
    Oral Oncol. 2020;111:104980.
    PubMed    


  533. JAYARAJ R, Shetty S, Kumaraswamy C, Raghul S, et al
    Clinical comments on prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2020;111:104886.
    PubMed    


    November 2020
  534. KOBAYASHI K, Yoshimoto S, Ando M, Matsumoto F, et al
    Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence.
    Oral Oncol. 2020;113:105091.
    PubMed     Abstract available


  535. MAZUL AL, Naik AN, Zhan KY, Stepan KO, et al
    Gender and race interact to influence survival disparities in head and neck cancer.
    Oral Oncol. 2020;112:105093.
    PubMed     Abstract available


  536. MASHIANA SS, Navale P, Khandakar B, Sobotka S, et al
    Human papillomavirus genotype distribution in head and neck cancer: Informing developing strategies for cancer prevention, diagnosis, treatment and surveillance.
    Oral Oncol. 2020;113:105109.
    PubMed     Abstract available


  537. ROY D, Patel A, Goswami G, Samantaray S, et al
    Role of Onco rehabilitation in head and neck cancer.
    Oral Oncol. 2020 Nov 19:105015. doi: 10.1016/j.oraloncology.2020.105015.
    PubMed    


  538. KHAN SA, Burke M, Zhu F, Yang DH, et al
    Survivin expression and impact on head and neck cancer outcomes.
    Oral Oncol. 2020;112:105049.
    PubMed     Abstract available


  539. ZHAO XT, Zhu Y, Zhou JF, Gao YJ, et al
    Development of a novel 7 immune-related genes prognostic model for oral cancer: A study based on TCGA database.
    Oral Oncol. 2020;112:105088.
    PubMed     Abstract available


  540. CHAKRABARTI D, Akhtar N, Qayoom S, Rajan S, et al
    Optimising elective neck dissection for early oral cancers.
    Oral Oncol. 2020 Nov 13:105090. doi: 10.1016/j.oraloncology.2020.105090.
    PubMed    


  541. WIJETUNGA NA, Yu Y, Morris LG, Lee N, et al
    The head and neck cancer genome in the era of immunotherapy.
    Oral Oncol. 2020;112:105040.
    PubMed     Abstract available


  542. ZHAI TT, Wesseling F, Langendijk JA, Shi Z, et al
    External validation of nodal failure prediction models including radiomics in head and neck cancer.
    Oral Oncol. 2020;112:105083.
    PubMed     Abstract available


  543. REGO-LORCA D, Burgos-Blasco B, Hernandez-Garcia E, Domingo-Gordo B, et al
    Abducens palsy as first manifestation of a nasopharyngeal carcinoma.
    Oral Oncol. 2020 Nov 10:105079. doi: 10.1016/j.oraloncology.2020.105079.
    PubMed    


  544. LIU AK, Wu J, Berthelet E, Lalani N, et al
    Clinical features of head and neck cancer patients with brain metastases: A retrospective study of 88 cases.
    Oral Oncol. 2020;112:105086.
    PubMed     Abstract available


  545. CHO JH, Lim YC
    Prognostic impact of regulatory T cell in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Oral Oncol. 2020;112:105084.
    PubMed     Abstract available


  546. HANNA GJ, Rettig EM, Park JC, Varvares MA, et al
    Hospitalization rates and 30-day all-cause mortality among head and neck cancer patients and survivors with COVID-19.
    Oral Oncol. 2020;112:105087.
    PubMed     Abstract available


  547. AMPIL F, Cuellar H, Nathan CA, Smith D, et al
    Recurrent head and neck cancers in the skull base, stereotactic radiosurgery palliation, and risk prognosticators.
    Oral Oncol. 2020 Nov 3:105005. doi: 10.1016/j.oraloncology.2020.105005.
    PubMed    


  548. SAKTHIVEL P, Samy K, Panda S, Amit Singh C, et al
    14 "S" in head and neck cancers.
    Oral Oncol. 2020;112:105070.
    PubMed    


  549. PANTA P
    Insights on betel-quid and coca chewing.
    Oral Oncol. 2020;110:104979.
    PubMed    


    October 2020
  550. AMPIL FL, Nathan CA, Asarkar A
    Long-term survival in patients with intermediate-risk head and neck cancer treated with adjuvant radiotherapy.
    Oral Oncol. 2020 Oct 30:105071. doi: 10.1016/j.oraloncology.2020.105071.
    PubMed    


  551. PANDOLFINI M, Di Stadio A, Brenner MJ, Pichi B, et al
    Airway obstruction from tracheostomy balloon cuff herniation during oral cancer asportation. Emergency successfully managed and lessons learnt from device malfunction.
    Oral Oncol. 2020 Oct 29:105048. doi: 10.1016/j.oraloncology.2020.105048.
    PubMed     Abstract available


  552. SAIDAK Z, Galmiche A, Lottin M, Montes L, et al
    The coagulome of Head and Neck Squamous Cell Carcinoma.
    Oral Oncol. 2020 Oct 28:105068. doi: 10.1016/j.oraloncology.2020.105068.
    PubMed    


  553. FLEMING CW, Ward MC, Woody NM, Joshi NP, et al
    Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.
    Oral Oncol. 2020;112:105046.
    PubMed     Abstract available


  554. MILLIET F, Bozec A, Schiappa R, Viotti J, et al
    Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study.
    Oral Oncol. 2020;112:105041.
    PubMed     Abstract available


  555. IMADUDDIN M, Sultania M, Vigneshwaran B, Muduly DK, et al
    Metronomic therapy using Methotrexate and Celecoxib: A Boon for Oral Cancer patients during COVID-19 Pandemic.
    Oral Oncol. 2020 Oct 24:105069. doi: 10.1016/j.oraloncology.2020.105069.
    PubMed    


  556. MORIKAWA T, Shibahara T, Takano M, Iwamoto M, et al
    Countermeasure and opportunistic screening systems for oral cancer.
    Oral Oncol. 2020;112:105047.
    PubMed     Abstract available


  557. GUPTA T, Ghosh-Laskar S, Agarwal JP
    Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era.
    Oral Oncol. 2020;111:105045.
    PubMed     Abstract available


  558. LEK SM, Li K, Tan QX, Shannon NB, et al
    Pairing a prognostic target with potential therapeutic strategy for head and neck cancer.
    Oral Oncol. 2020;111:105035.
    PubMed     Abstract available


  559. FERRARI M, Paderno A, Giannini L, Cazzador D, et al
    COVID-19 screening protocols for preoperative assessment of head and neck cancer patients candidate for elective surgery in the midst of the pandemic: A narrative review with comparison between two Italian institutions.
    Oral Oncol. 2020;112:105043.
    PubMed     Abstract available


  560. PARK JC, Durbeck J, Clark JR, Faden DL, et al
    Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes.
    Oral Oncol. 2020;111:105024.
    PubMed     Abstract available


  561. DE VRIES J, Bras L, Sidorenkov G, Festen S, et al
    Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer.
    Oral Oncol. 2020;111:105020.
    PubMed     Abstract available


  562. CONTRERA KJ, Smile TD, Mahomva C, Wei W, et al
    Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
    Oral Oncol. 2020;111:105030.
    PubMed     Abstract available


  563. HUANG S, Piao Y, Cao C, Chen J, et al
    A prospective randomized controlled trial on the value of prophylactic oral nutritional supplementation in locally advanced nasopharyngeal carcinoma patients receiving chemo-radiotherapy.
    Oral Oncol. 2020;111:105025.
    PubMed     Abstract available


  564. FORNER D, Noel CW, Wu V, Parmar A, et al
    Nonsurgical management of resectable oral cavity cancer in the wake of COVID-19: A rapid review and meta-analysis.
    Oral Oncol. 2020;109:104849.
    PubMed     Abstract available


  565. ROUTRAY S, Mishra P
    A probable surge in oral lichen planus cases under the aura of coronavirus in females in India.
    Oral Oncol. 2020;109:104714.
    PubMed    


  566. SUBRAMANIAM N, Dhar SK, Rao R, Prasad K, et al
    Novel tyrosine metabolites in the transcriptomic profiling of smokeless tobacco related oral cancer and their potential implications.
    Oral Oncol. 2020 Oct 1:105027. doi: 10.1016/j.oraloncology.2020.105027.
    PubMed    


  567. CUSTODIO M, Biddle A, Tavassoli M
    Portrait of a CAF: The story of cancer-associated fibroblasts in head and neck cancer.
    Oral Oncol. 2020;110:104972.
    PubMed     Abstract available


  568. TRETIAKOW D, Stodulski D, Skorek A
    Regarding the concurrent presence of secretory carcinoma and Warthin's tumor in the ipsilateral parotid gland.
    Oral Oncol. 2020;109:104763.
    PubMed    


  569. JOSHNA BM, Subash A, Thakur S, Rao V, et al
    Time to revisit the tumor margins in post NACT oral squamous cell carcinoma.
    Oral Oncol. 2020;109:104679.
    PubMed    


    September 2020
  570. CHOW JCH, Tam AHP, Cheung KM, Lee VHF, et al
    Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: A territory-wide study by HKNPCSG.
    Oral Oncol. 2020;111:105012.
    PubMed     Abstract available


  571. ECONOMOPOULOU P, Kotsantis I, Papaxoinis G, Gavrielatou N, et al
    Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
    Oral Oncol. 2020;111:105013.
    PubMed     Abstract available


  572. RAPADO-GONZALEZ O, Muinelo-Romay L, Suarez-Cunqueiro MM
    Letter to the editor: "Liquid biopsy based on saliva cell-free DNA as a potential biomarker for head and neck cancer".
    Oral Oncol. 2020 Sep 21:105016. doi: 10.1016/j.oraloncology.2020.105016.
    PubMed    


  573. YETE S, Saranath D
    MicroRNAs in oral cancer: Biomarkers with clinical potential.
    Oral Oncol. 2020;110:105002.
    PubMed     Abstract available


  574. YEH CF, Ho CY, Chin YC, Shu CH, et al
    Pretreatment age and serum lactate dehydrogenase as predictors of synchronous second primary cancer in patients with nasopharyngeal carcinoma.
    Oral Oncol. 2020;110:104990.
    PubMed     Abstract available


  575. GRILLI G, Hermida-Prado F, Alvarez-Fernandez M, Allonca E, et al
    Impact of notch signaling on the prognosis of patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2020;110:105003.
    PubMed     Abstract available


  576. ZHANG L, Li B, Peng Y, Wu F, et al
    The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Oral Oncol. 2020;110:104943.
    PubMed     Abstract available


  577. TU X, Ren J, Zhao Y
    Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Oral Oncol. 2020;110:104991.
    PubMed     Abstract available


  578. BAGHIZADEH FINI M
    Oral saliva and COVID-19.
    Oral Oncol. 2020;108:104821.
    PubMed     Abstract available


  579. MARTIN M, Sautois B
    Early onset of head and neck squamous-cell carcinoma and fatal toxicity with concurrent chemoradiotherapy in a patient compound heterozygote for FANCA gene.
    Oral Oncol. 2020 Sep 1:104989. doi: 10.1016/j.oraloncology.2020.104989.
    PubMed    


  580. HERRERA GOMEZ RG, Saleh K, Mayache L, Iacob M, et al
    Panitumumab as an effective maintenance treatment in metastatic squamous cell carcinoma of the head and neck.
    Oral Oncol. 2020 Sep 1:104984. doi: 10.1016/j.oraloncology.2020.104984.
    PubMed    


  581. WANG M, Zhu F, Luo N, Han T, et al
    A case report of a patient with first phenotype of papillary thyroid carcinoma and heterochronous multiprimary tumor harboring germline MUTYH Arg19*/Gly286Glu mutations.
    Oral Oncol. 2020 Sep 1:104987. doi: 10.1016/j.oraloncology.2020.104987.
    PubMed     Abstract available


  582. JAYARAJ R, Shetty SS, Kumaraswamy C, Gothandam KM, et al
    Clinical interpretation of findings from a systematic review and a comprehensive meta-analysis on clinicopathological and prognostic characteristics of oral squamous cell carcinomas (OSCC) arising in patients with oral lichen planus (OLP).
    Oral Oncol. 2020;108:104974.
    PubMed    


  583. VAN DE GRAAF RC
    Smoking cessation counseling by physicians and dentists - Shouldn't a cobbler stick to his last?
    Oral Oncol. 2020;108:104952.
    PubMed    


    August 2020
  584. FAKHRY C, Fung N, Tewari SR, D'Souza G, et al
    Unique role of HPV16 in predicting oropharyngeal cancer risk more than other oncogenic oral HPV infections.
    Oral Oncol. 2020 Aug 29:104981. doi: 10.1016/j.oraloncology.2020.104981.
    PubMed    


  585. HE L, Xiao J, Wei Z, He Y, et al
    Toxicity and dosimetric analysis of nasopharyngeal carcinoma patients undergoing radiotherapy with IMRT or VMAT: A regional center's experience.
    Oral Oncol. 2020;109:104978.
    PubMed     Abstract available


  586. SCOTT SE, Oakley R, Moller H, Warburton F, et al
    Tracking cancer occurrence in the 5 years after referral for suspected head and neck cancer.
    Oral Oncol. 2020;109:104955.
    PubMed     Abstract available


  587. ELBEHI AM, Anu RI, Ekine-Afolabi B, Cash E, et al
    Emerging role of immune checkpoint inhibitors and predictive biomarkers in head and neck cancers.
    Oral Oncol. 2020;109:104977.
    PubMed     Abstract available


  588. SINGH A, Singh CA, Sikka K
    Classification of three prognostically different groups of Head and Neck Cancer patients based on their metabolic response to induction chemotherapy (IC-1).
    Oral Oncol. 2020 Aug 21:104936. doi: 10.1016/j.oraloncology.2020.104936.
    PubMed    


  589. SHAIKH MH, Barrett JW, Khan MI, Kim HAJ, et al
    Chromosome 3p loss in the progression and prognosis of head and neck cancer.
    Oral Oncol. 2020;109:104944.
    PubMed     Abstract available


  590. BARLAK N, Capik O, Sanli F, Karatas OF, et al
    The roles of microRNAs in the stemness of oral cancer cells.
    Oral Oncol. 2020;109:104950.
    PubMed     Abstract available


  591. PAWAR P, Vaishampayan S, Shah DH, Pai A, et al
    Retro-auricular endo assisted selective neck dissection (how I do it).
    Oral Oncol. 2020;110:104942.
    PubMed     Abstract available


  592. HACKMAN TG, Patel SN, Deal AM, Neil Hayes D, et al
    Novel induction therapy transoral surgery treatment paradigm with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck - Mature clinical and functional outcomes.
    Oral Oncol. 2020;110:104957.
    PubMed     Abstract available


  593. MAHAJAN A, Ahuja A, Sable N, Stambuk HE, et al
    Corrigendum to "Imaging in oral cancers: A comprehensive review" [Oral Oncol. 104 (2020) 104658].
    Oral Oncol. 2020;111:104956.
    PubMed    


  594. WICKER CA, Takiar V, Suganya R, Arnold SM, et al
    Evaluation of antioxidant network proteins as novel prognostic biomarkers for head and neck cancer patients.
    Oral Oncol. 2020;111:104949.
    PubMed     Abstract available


  595. PARK JC, Durbeck J, Boudadi K, Ho WJ, et al
    The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma.
    Oral Oncol. 2020 Aug 10:104935. doi: 10.1016/j.oraloncology.2020.104935.
    PubMed    


  596. MOON JH, Lee SH, Koo BS, Kim JM, et al
    Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
    Oral Oncol. 2020;111:104948.
    PubMed     Abstract available


  597. CHEN TC, Wu CT, Wang CP, Lou PJ, et al
    The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
    Oral Oncol. 2020;111:104945.
    PubMed     Abstract available


  598. VAN LANSCHOT CGF, Klazen YP, de Ridder MAJ, Mast H, et al
    Depth of invasion in early stage oral cavity squamous cell carcinoma: The optimal cut-off value for elective neck dissection.
    Oral Oncol. 2020;111:104940.
    PubMed     Abstract available


  599. WANG J, Lian CL, Zheng H, Lin LE, et al
    Cognitive dysfunction in patients with nasopharyngeal carcinoma after induction chemotherapy.
    Oral Oncol. 2020;111:104921.
    PubMed     Abstract available


  600. DENARO N, Merlotti AM, Merlano MC, Russi E, et al
    Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC).
    Oral Oncol. 2020;107:104801.
    PubMed    


  601. MOTTA ACF, Rodrigues KRDH
    Could we benefit from oral self-examination during the COVID-19 pandemic?
    Oral Oncol. 2020;107:104840.
    PubMed    


  602. GALLO O, Trotta M, Orlando P, Maggiore G, et al
    SARS-CoV-2 in upper and lower airway samples of a laryngectomized patient: New insights and many lessons.
    Oral Oncol. 2020;107:104841.
    PubMed    


  603. KOCHHAR AS, Bhasin R, Kochhar GK, Dadlani H, et al
    Diagnostic Tests for SARS-CoV-2: Implications in Head and Neck Oncology.
    Oral Oncol. 2020;107:104813.
    PubMed    


  604. GEORGE CK, Varghese BT, Divya GM, Janardhan D, et al
    Emergency tracheostomy during COVID 19 pandemic in a head and neck surgical oncology unit.
    Oral Oncol. 2020;107:104784.
    PubMed    


  605. DENARO N, Merlotti AM, Merlano MC, Russi E, et al
    Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC).
    Oral Oncol. 2020;107:104801.
    PubMed    


  606. PARRINELLO G, Missale F, Sampieri C, Carobbio ALC, et al
    Safe management of laryngectomized patients during the COVID-19 pandemic.
    Oral Oncol. 2020;107:104742.
    PubMed    


  607. DENARO N, Merlotti AM, Merlano MC, Russi E, et al
    Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC).
    Oral Oncol. 2020;107:104801.
    PubMed    


    July 2020
  608. ZENG YY, Xiang ZZ, He T, Liu F, et al
    The comparison of prognostic value of tumour volumetric regression ratio and RECIST 1.1 criteria after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2020;111:104924.
    PubMed     Abstract available


  609. WANG Q, Xu G, Xia Y, Zuo J, et al
    Comparison of induction chemotherapy plus concurrent chemoradiotherapy and induction chemotherapy plus radiotherapy in locally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2020;111:104925.
    PubMed     Abstract available


  610. NEWTON H, Mcrae AB, Shanahan D
    The dangers of delaying treatment in oral cancer: A seventeenth-century perspective.
    Oral Oncol. 2020 Jul 23:104911. doi: 10.1016/j.oraloncology.2020.104911.
    PubMed    


  611. LI W, Lu H, Liu J, Liu Q, et al
    A novel nomogram to predict survival in patients with recurrent nasopharyngeal carcinoma after salvage endoscopic surgery.
    Oral Oncol. 2020;111:104922.
    PubMed     Abstract available


  612. YANG YH, Warnakulasuriya S, Yang HF, Lin LJ, et al
    Public health measures to reduce areca nut and betel quid use for control of oral cancer in Taiwan.
    Oral Oncol. 2020 Jul 22:104915. doi: 10.1016/j.oraloncology.2020.104915.
    PubMed    


  613. D'SOUZA W, Kumar A
    microRNAs in oral cancer: Moving from bench to bed as next generation medicine.
    Oral Oncol. 2020;111:104916.
    PubMed     Abstract available


  614. MARTELLI-JUNIOR H, Machado RA, Martelli DRB, Andrade MC, et al
    Oral cancer and ACE2 receptor of SARS-CoV-2.
    Oral Oncol. 2020 Jul 21:104920. doi: 10.1016/j.oraloncology.2020.104920.
    PubMed    


  615. BONOMI M, Bhateja P, Issa M, Klamer B, et al
    A predictive survival model for patients with head and neck squamous cell carcinoma treated with immune check point inhibitors.
    Oral Oncol. 2020;110:104900.
    PubMed     Abstract available


  616. STEPAN KO, Li MM, Kang SY, Puram SV, et al
    Molecular margins in head and neck cancer: Current techniques and future directions.
    Oral Oncol. 2020;110:104893.
    PubMed     Abstract available


  617. MCDOWELL L, So N, Keshavarzi S, Xu W, et al
    Sexual satisfaction in nasopharyngeal carcinoma survivors: Rates and determinants.
    Oral Oncol. 2020;109:104865.
    PubMed     Abstract available


  618. YANG H, Liu Y, Zhang R, Ye Y, et al
    Prognostic value of the tumor volume reduction rate after neoadjuvant chemotherapy in patients with locoregional advanced nasopharyngeal carcinoma.
    Oral Oncol. 2020;110:104897.
    PubMed     Abstract available


  619. SCHORN L, Lommen J, Sproll C, Kruskemper G, et al
    Evaluation of patient specific care needs during treatment for head and neck cancer.
    Oral Oncol. 2020;110:104898.
    PubMed     Abstract available


  620. HSU AC, Kokot NC, Eisenberg BL, Thomas JS, et al
    Complete response with talimogene laherparepvec in recurrent melanoma of the ear: A case report.
    Oral Oncol. 2020 Jul 11:104899. doi: 10.1016/j.oraloncology.2020.104899.
    PubMed     Abstract available


  621. BRINKMAN D, Callanan D, O'Shea R, Jawad H, et al
    Impact of 3 mm margin on risk of recurrence and survival in oral cancer.
    Oral Oncol. 2020;110:104883.
    PubMed     Abstract available


  622. MATOS LL, Pinheiro RA, Kowalski LP
    Depth of invasion applied to oropharynx does not improve prognosis discrimination according to AJCC stage groups for oral cancer.
    Oral Oncol. 2020 Jul 9:104890. doi: 10.1016/j.oraloncology.2020.104890.
    PubMed    


  623. HUNG TM, Fan KH, Kang CJ, Huang SF, et al
    Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma.
    Oral Oncol. 2020;110:104756.
    PubMed     Abstract available


  624. LI X, Lee A, Cohen MA, Sherman EJ, et al
    Past, present and future of proton therapy for head and neck cancer.
    Oral Oncol. 2020;110:104879.
    PubMed     Abstract available


  625. OSAZUWA-PETERS N, Barnes JM, Megwalu U, Adjei Boakye E, et al
    State Medicaid expansion status, insurance coverage and stage at diagnosis in head and neck cancer patients.
    Oral Oncol. 2020;110:104870.
    PubMed     Abstract available


  626. CHEN G, Wu Q, Jiang H, Zhong Y, et al
    The impact of the COVID-19 pandemic on head and neck cancer patients.
    Oral Oncol. 2020 Jul 2:104881. doi: 10.1016/j.oraloncology.2020.104881.
    PubMed    


  627. TRIBIUS S, Pazdyka H, Tennstedt P, Busch CJ, et al
    Prognostic factors for lymphedema in patients with locally advanced head and neck cancer after combined radio(chemo)therapy- results of a longitudinal study.
    Oral Oncol. 2020;109:104856.
    PubMed     Abstract available


  628. VARGHESE BT
    Covid19 pandemic; A practicing head and neck surgeon's perspective of an institutional model.
    Oral Oncol. 2020;106:104765.
    PubMed    


  629. SUBASH A, Sinha P, Singh A
    BRAF mutation and age in differentiated thyroid cancer risk stratification: Two sides of the same coin.
    Oral Oncol. 2020;106:104732.
    PubMed     Abstract available


  630. BRCIC I, Gallob M, Schwantzer G, Zrnc T, et al
    Concordance of tumor infiltrating lymphocytes, PD-L1 and p16 expression in small biopsies, resection and lymph node metastases of oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2020;106:104719.
    PubMed     Abstract available


  631. LENOUVEL D, Gonzalez-Moles MA, Ruiz-Avila I, Gonzalez-Ruiz L, et al
    Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis.
    Oral Oncol. 2020;106:104722.
    PubMed     Abstract available


  632. WANG YP, Liu IJ, Chung MJ, Wu HC, et al
    Novel anti-EGFR scFv human antibody-conjugated immunoliposomes enhance chemotherapeutic efficacy in squamous cell carcinoma of head and neck.
    Oral Oncol. 2020;106:104689.
    PubMed     Abstract available


  633. CHUANG ST, Chen CC, Yang SF, Chan LP, et al
    Tumor histologic grade as a risk factor for neck recurrence in patients with T1-2N0 early tongue cancer.
    Oral Oncol. 2020;106:104706.
    PubMed     Abstract available


  634. COHEN ER, Reis IM, Gomez-Fernandez C, Smith D, et al
    CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients.
    Oral Oncol. 2020;106:104720.
    PubMed     Abstract available


  635. KISHIMOTO Y, Tateya I, Funakoshi M, Miyamoto SI, et al
    Endoscopic laryngopharyngeal surgery for hypopharyngeal lesions.
    Oral Oncol. 2020;106:104655.
    PubMed     Abstract available


  636. SEKARUTAMI SM, Gondhowiardjo S, Yuliasti R, Syarifah L, et al
    Survival of nasopharyngeal cancer in national referral hospital of Indonesia: A study on radiotherapy patients.
    Oral Oncol. 2020;106:104707.
    PubMed     Abstract available


  637. GONZALEZ-MOLES MA, Warnakulasuriya S, Gonzalez-Ruiz I, Gonzalez-Ruiz L, et al
    Clinicopathological and prognostic characteristics of oral squamous cell carcinomas arising in patients with oral lichen planus: A systematic review and a comprehensive meta-analysis.
    Oral Oncol. 2020;106:104688.
    PubMed     Abstract available


  638. KU JY, Roh JL, Cho KJ, Song JS, et al
    Risk factors for survival of head and neck soft tissue sarcomas: A comparison between 7th and 8th edition AJCC staging systems.
    Oral Oncol. 2020;106:104705.
    PubMed     Abstract available


  639. FERRARI M, Ioppi A, Schreiber A, Gualtieri T, et al
    Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients.
    Oral Oncol. 2020;106:104672.
    PubMed     Abstract available


  640. ZAID M, Koay EJ, Bajaj N, Mathew R, et al
    A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods.
    Oral Oncol. 2020;106:104665.
    PubMed     Abstract available


    June 2020
  641. KATSOULAKIS E, Yu Y, Apte AP, Leeman JE, et al
    Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma.
    Oral Oncol. 2020;110:104877.
    PubMed     Abstract available


  642. QUER M, Leon X, Casasayas M, Sansa A, et al
    Salvage surgery in head and neck cancer: External validation of predictors of disease-specific survival.
    Oral Oncol. 2020;109:104876.
    PubMed     Abstract available


  643. KE L, Deng Y, Xia W, Qiang M, et al
    Development of a self-constrained 3D DenseNet model in automatic detection and segmentation of nasopharyngeal carcinoma using magnetic resonance images.
    Oral Oncol. 2020;110:104862.
    PubMed     Abstract available


  644. LIU K, Lin S, Ke L, Xia W, et al
    Prognostic value and the potential role of treatment options for cervical lymph node necrosis in nasopharyngeal carcinoma.
    Oral Oncol. 2020;109:104864.
    PubMed     Abstract available


  645. LIU C, Liao L, Wu G, Yan H, et al
    Radiation-induced second primary squamous cell carcinoma of the oral cavity after radiotherapy for nasopharyngeal carcinoma.
    Oral Oncol. 2020;109:104863.
    PubMed     Abstract available


  646. BORSETTO D, Fussey J, Fabris L, Bandolin L, et al
    HCV infection and the risk of head and neck cancer: A meta-analysis.
    Oral Oncol. 2020;109:104869.
    PubMed     Abstract available


  647. VIET CT, Dierks EJ, Cheng AC, Patel AA, et al
    Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: Importance of nodal count in survival.
    Oral Oncol. 2020;109:104770.
    PubMed     Abstract available


  648. MES SW, Brink A, Sistermans EA, Straver R, et al
    Comprehensive multiparameter genetic analysis improves circulating tumor DNA detection in head and neck cancer patients.
    Oral Oncol. 2020;109:104852.
    PubMed     Abstract available


  649. KAR A, M R A, Bhaumik U, Rao VUS, et al
    Psychological issues in head and neck cancer survivors: Need for addressal in rehabilitation.
    Oral Oncol. 2020 Jun 18:104859. doi: 10.1016/j.oraloncology.2020.104859.
    PubMed     Abstract available


  650. HAN HR, Hermann GM, Ma SJ, Iovoli AJ, et al
    Matched pair analysis to evaluate the impact of hospitalization during radiation therapy as an early marker of survival in head and neck cancer patients.
    Oral Oncol. 2020;109:104854.
    PubMed     Abstract available


  651. CHU C, Sun Y, Pan Y
    Immunotherapy is a preferred option for oral cancer patients during COVID-19 pandemic?
    Oral Oncol. 2020 Jun 15:104860. doi: 10.1016/j.oraloncology.2020.104860.
    PubMed    


  652. WOODS LT, Jasmer KJ, Munoz Forti K, Shanbhag VC, et al
    P2Y2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines.
    Oral Oncol. 2020;109:104808.
    PubMed     Abstract available


  653. MAHAJAN A, Ahuja A, Sable N, Stambuk HE, et al
    Reply to letter to editor - Dr Arya's response to "Imaging in oral cancers: A comprehensive review".
    Oral Oncol. 2020 Jun 10:104847. doi: 10.1016/j.oraloncology.2020.104847.
    PubMed    


  654. LECHIEN JR, Fakhry N, Saussez S, Chiesa-Estomba CM, et al
    Surgical, clinical and functional outcomes of transoral robotic surgery for supraglottic laryngeal cancers: A systematic review.
    Oral Oncol. 2020;109:104848.
    PubMed     Abstract available


  655. LIN TY, Lan MY, Tsou HH, Ho CY, et al
    Survival impacts of different nodal characteristics and T-classification in N3 nasopharyngeal carcinoma patients.
    Oral Oncol. 2020;108:104820.
    PubMed     Abstract available


  656. GARCIA-MARTIN JM, Garcia-Pola MJ, Varela-Centelles P, Seoane-Romero JM, et al
    On the role of physicians in oral cancer diagnosis.
    Oral Oncol. 2020;108:104843.
    PubMed    


  657. ALESSANDRINI L, Franz L, Ottaviano G, Ghi MG, et al
    Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma.
    Oral Oncol. 2020;108:104836.
    PubMed     Abstract available


  658. KAUL P, Singh MP, Pasricha R, Garg PK, et al
    Methotrexate based oral chemotherapy for advanced oral cancer during COVID-19 pandemic: Another option in the therapeutic armamentarium.
    Oral Oncol. 2020 Jun 4:104839. doi: 10.1016/j.oraloncology.2020.104839.
    PubMed    


  659. KREIMER AR, Chaturvedi AK, Alemany L, Anantharaman D, et al
    Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI.
    Oral Oncol. 2020;108:104736.
    PubMed     Abstract available


  660. DAY AT, Sher DJ, Lee RC, Truelson JM, et al
    Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment paradigms in light of new surgical and other multilevel risks.
    Oral Oncol. 2020;105:104684.
    PubMed     Abstract available


  661. MADY LJ, Kubik MW, Baddour K, Snyderman CH, et al
    Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as "Personal Protective Equipment" for frontline providers exposed in high-risk head and neck and skull base oncology care.
    Oral Oncol. 2020;105:104724.
    PubMed    


  662. SHETTY SS, Rao V, Kudpaje A, Mithra S, et al
    An oncologist perspective on COVID 19: A mysterious cryptic virus.
    Oral Oncol. 2020;105:104694.
    PubMed    


  663. SCHOENFELD JD, Fell G, Haddad RI, Trippa L, et al
    Keynote 48: Is it really for everyone?
    Oral Oncol. 2020;105:104762.
    PubMed    


  664. IQBAL MS, Warner L, Paleri V, Kovarik J, et al
    De-intensification of treatment in human papilloma virus related oropharyngeal carcinoma: Patient choice still matters for de-escalation and for the COVID era.
    Oral Oncol. 2020;105:104768.
    PubMed    


  665. VAN GERWEN M, Alpert N, Sinclair C, Kale M, et al
    Assessing non-aggressiveness of untreated, local and regional, papillary thyroid cancer.
    Oral Oncol. 2020;105:104674.
    PubMed     Abstract available


  666. PATIL VM, Noronha V, Joshi A, Abhyankar A, et al
    Beyond conventional chemotherapy, targeted therapy and immunotherapy in squamous cell cancer of the oral cavity.
    Oral Oncol. 2020;105:104673.
    PubMed     Abstract available


  667. KOYAMA S, Tabuchi T, Okawa S, Morishima T, et al
    Oral cavity cancer incidence rates in Osaka, Japan between 2000 and 2014.
    Oral Oncol. 2020;105:104653.
    PubMed     Abstract available


  668. SASAKI CT, Hajek M, Doukas SG, Vageli DP, et al
    The role of bile reflux and its related NF-kappaB activated pathway in progression of hypopharyngeal squamous cell cancer.
    Oral Oncol. 2020;105:104668.
    PubMed     Abstract available


  669. BIGELOW EO, Seiwert TY, Fakhry C
    Deintensification of treatment for human papillomavirus-related oropharyngeal cancer: Current state and future directions.
    Oral Oncol. 2020;105:104652.
    PubMed     Abstract available


  670. DURAN-SIERRA E, Cheng S, Cuenca-Martinez R, Malik B, et al
    Clinical label-free biochemical and metabolic fluorescence lifetime endoscopic imaging of precancerous and cancerous oral lesions.
    Oral Oncol. 2020;105:104635.
    PubMed     Abstract available


  671. JANK BJ, Kadletz L, Dunkler D, Haas M, et al
    Epithelial stem cell marker LGR6 expression identifies a low-risk subgroup in human papillomavirus positive oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2020;105:104657.
    PubMed     Abstract available


  672. FERRARI M, Sahovaler A, Chan HHL, Nicolai P, et al
    Scapular tip-thoracodorsal artery perforator free flap for total/subtotal glossectomy defects: Case series and conformance study.
    Oral Oncol. 2020;105:104660.
    PubMed     Abstract available


    May 2020
  673. FARQUHAR DR, Coniglio AJ, Masood MM, Lenze N, et al
    Evaluation of pathologic staging using number of nodes in p16-negative head and neck cancer.
    Oral Oncol. 2020;108:104800.
    PubMed     Abstract available


  674. MAZUL AL, Stepan KO, Barrett TF, Thorstad WL, et al
    Duration of radiation therapy is associated with worse survival in head and neck cancer.
    Oral Oncol. 2020;108:104819.
    PubMed     Abstract available


  675. RIVA G, Pizzo C, Fassone E, Pecorari G, et al
    Head and neck cancer surgery in COVID-19 pandemic in Northern Italy.
    Oral Oncol. 2020 May 30:104835. doi: 10.1016/j.oraloncology.2020.104835.
    PubMed    


  676. BEDDOK A, Krieger S, Castera L, Stoppa-Lyonnet D, et al
    Management of Fanconi Anemia patients with head and neck carcinoma: Diagnosis and treatment adaptation.
    Oral Oncol. 2020;108:104816.
    PubMed     Abstract available


  677. SUBRAMANIAM N, Clark JR, Goldstein D, de Almeida J, et al
    Stage pN3a in oral cancer: A redundant entity?
    Oral Oncol. 2020 May 25:104815. doi: 10.1016/j.oraloncology.2020.104815.
    PubMed    


  678. DAY D, Prawira A, Spreafico A, Waldron J, et al
    Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck.
    Oral Oncol. 2020;108:104753.
    PubMed     Abstract available


  679. YIN CH, Kang BH, Liu WS, Pan LF, et al
    New prediction tool-LIST-with improved prediction accuracy for 30-day readmission rates in patients with head and neck cancer after major cancer surgery.
    Oral Oncol. 2020;108:104772.
    PubMed     Abstract available


  680. SULTANIA M, Muduly D, Imaduddin M, Kar M, et al
    Oral Cancer Surgery and COVID pandemic - Metronomic Therapy shows a promising role while awaiting surgery.
    Oral Oncol. 2020 May 22:104814. doi: 10.1016/j.oraloncology.2020.104814.
    PubMed    


  681. CHOI SY, Lee DW, Song B, Kim SY, et al
    A rapid quantification of invasive phenotype in head and neck squamous cell carcinoma: A novel 3D pillar array system.
    Oral Oncol. 2020;108:104807.
    PubMed     Abstract available


  682. DEVARAJA K
    Surgical sequence of neck dissection and primary tumor excision could impact the locoregional recurrence rates in oral squamous cell carcinoma.
    Oral Oncol. 2020 May 21:104809. doi: 10.1016/j.oraloncology.2020.104809.
    PubMed    


  683. JOO YH, Cho KJ, Kim GJ, Kim MS, et al
    Prognostic impact of resection margin involvement in surgically managed HPV-positive tonsil cancer.
    Oral Oncol. 2020;108:104806.
    PubMed     Abstract available


  684. SU SY, Chen WT, Chiang CJ, Yang YW, et al
    Oral cancer incidence rates from 1997 to 2016 among men in Taiwan: Association between birth cohort trends and betel nut consumption.
    Oral Oncol. 2020;107:104798.
    PubMed     Abstract available


  685. ZHOU K, Li Y, Liao W, Zhang M, et al
    Pembrolizumab alone or with chemotherapy for squamous cell carcinoma of the head and neck: A cost-effectiveness analysis from Chinese perspective.
    Oral Oncol. 2020;107:104754.
    PubMed     Abstract available


  686. OU D, Wang X, Xue F, Niu X, et al
    Is nasopharyngeal carcinoma in young patients a distinct clinical entity? A single-institution case matched analysis in the era of intensity-modulated radiotherapy.
    Oral Oncol. 2020;107:104779.
    PubMed     Abstract available


  687. KAUL P, Kumar R, Singh MP, Garg PK, et al
    Baffling posterior belly of digastric muscle during neck dissection.
    Oral Oncol. 2020 May 12:104783. doi: 10.1016/j.oraloncology.2020.104783.
    PubMed    


  688. KYLMA AK, Jouhi L, Mohamed H, Randen-Brady R, et al
    In HPV-negative oropharyngeal squamous cell carcinoma, elevated toll-like receptor 2 immunoexpression may increase the risk of disease-specific mortality.
    Oral Oncol. 2020;107:104778.
    PubMed     Abstract available


  689. JAYARAJ R, Shetty S, Kumaraswamy C, Raymond G, et al
    Clinical validity and conceptual interpretation of systematic review and meta-analysis on elective neck dissection (END) versus observation for early-stage oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2020 May 8:104764. doi: 10.1016/j.oraloncology.2020.104764.
    PubMed    


  690. LOCATELLO LG, Bruno C, Pietragalla M, Taverna C, et al
    A critical evaluation of computed tomography-derived depth of invasion in the preoperative assessment of oral cancer staging.
    Oral Oncol. 2020;107:104749.
    PubMed     Abstract available


  691. LEE J, Kim WC, Yoon WS, Koom WS, et al
    Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: A meta-analysis and systematic review.
    Oral Oncol. 2020;107:104757.
    PubMed     Abstract available


  692. ARAVIND S, Pandiar D, Nayanar SK, Babu S, et al
    Nodal metastasis from papillary thyroid carcinoma (PTC) with no evidence of primary tumor in the thyroid gland: Case report and literature review.
    Oral Oncol. 2020 May 6:104761. doi: 10.1016/j.oraloncology.2020.104761.
    PubMed    


  693. HALBOUB E, Al-Maweri SA, Al-Soneidar WA
    Utilization of COVID-19 testing for opportunistic screening of oral cancer.
    Oral Oncol. 2020 May 6:104775. doi: 10.1016/j.oraloncology.2020.104775.
    PubMed    


  694. JANG HS, Choi SY
    Oral squamous cell carcinoma around dental implant mimicking peri-implantitis.
    Oral Oncol. 2020 May 6:104759. doi: 10.1016/j.oraloncology.2020.104759.
    PubMed    


  695. VARGHESE BT
    The Kerala Model of health care delivery and its impact on Oral cancer care during the COVID 19 pandemic.
    Oral Oncol. 2020 May 3:104769. doi: 10.1016/j.oraloncology.2020.104769.
    PubMed    


  696. AL-MAWERI SA, Halboub E, Warnakulasuriya S
    Impact of COVID-19 on the early detection of oral cancer: A special emphasis on high risk populations.
    Oral Oncol. 2020 May 3:104760. doi: 10.1016/j.oraloncology.2020.104760.
    PubMed    


  697. VALENTINI V, Pucci R, Battisti A, Cassoni A, et al
    Head and neck cancer cannot wait for this pandemic to end: Risks, challenges and perspectives of oral-maxillofacial surgeon during COVID-19.
    Oral Oncol. 2020 May 1:104758. doi: 10.1016/j.oraloncology.2020.104758.
    PubMed    


  698. TSAI YF, Wang YY, Yuan SF
    Comet tail, an indicator for DNA damage or repair?: Refers to Liu et al. Oral Oncology 2020 Jan;100:104469.
    Oral Oncol. 2020;104:104624.
    PubMed    


  699. LU Y, Wang Q
    Letter regarding "Association between dietary inflammatory index and upper aerodigestive tract cancer risk: A systematic review and dose-response meta-analysis".
    Oral Oncol. 2020;104:104619.
    PubMed    


  700. MARCHI F, Al Deek NF
    Letter to Editors Regarding, "Assessment of fibula flap with flexor hallucis longus's effect on head & neck tumor patients' quality of life and function of donor site": Ethics, Surgical Technique, and QoL Measures.
    Oral Oncol. 2020;104:104620.
    PubMed    


  701. YAN L, Chen F, Chen L, Lin J, et al
    Dynamic evaluation of conditional survival in patients with oral squamous cell carcinoma after surgical resection: A large-scale prospective study.
    Oral Oncol. 2020;104:104639.
    PubMed     Abstract available


  702. MANNELLI G, Gazzini L, Comini LV, Parrinello G, et al
    Double free flaps in oral cavity and oropharynx reconstruction: Systematic review, indications and limits.
    Oral Oncol. 2020;104:104637.
    PubMed     Abstract available


  703. CHATTERJEE A, Laskar SG, Chaukar D
    Management of early oral cavity squamous cancers.
    Oral Oncol. 2020;104:104627.
    PubMed     Abstract available


  704. MUNDI N, Ghasemi F, Zeng PYF, Prokopec SD, et al
    Sex disparities in head & neck cancer driver genes: An analysis of the TCGA dataset.
    Oral Oncol. 2020;104:104614.
    PubMed     Abstract available


  705. PAN L, Chen Y, Li S, Ouyang W, et al
    Postoperative thyroid remnants for differentiated thyroid cancer may not affect the outcome of high-dose radioiodine therapy.
    Oral Oncol. 2020;104:104610.
    PubMed     Abstract available


  706. KAR A, Adeniji A, Rao VUS, Ghosh M, et al
    Molecular landscape of salivary gland cancers.
    Oral Oncol. 2020;104:104595.
    PubMed     Abstract available


    April 2020
  707. SCHROEDER L, Pring M, Ingarfield K, Pawlita M, et al
    HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer.
    Oral Oncol. 2020;107:104721.
    PubMed     Abstract available


  708. JUNG AR, Roh JL, Kim JS, Choi SH, et al
    Post-treatment (18)F-FDG PET/CT for predicting survival and recurrence in patients with advanced-stage head and neck cancer undergoing curative surgery.
    Oral Oncol. 2020;107:104750.
    PubMed     Abstract available


  709. WEN DW, Li ZX, Chen FP, Lin L, et al
    Individualized cumulative cisplatin dose for locoregionally-advanced nasopharyngeal carcinoma patients receiving induction chemotherapy and concurrent chemoradiotherapy.
    Oral Oncol. 2020;107:104675.
    PubMed     Abstract available


  710. ARYA S
    Letter to Editor in response to "Imaging in oral cancers: A comprehensive review. Oral Oncology 2020, 21;104:104658. Mahajan A, Ahuja A, Sable N, Stambuk HE".
    Oral Oncol. 2020 Apr 27:104735. doi: 10.1016/j.oraloncology.2020.104735.
    PubMed    


  711. LEONEL ACLDS, Martelli-Junior H, Bonan PRF, Kowalski LP, et al
    COVID-19, head and neck cancer, and the need of training of health students and practitioners regarding to tobacco control and patient counseling.
    Oral Oncol. 2020 Apr 24:104739. doi: 10.1016/j.oraloncology.2020.104739.
    PubMed    


  712. CHAVES ALF, Castro AF, Marta GN, Junior GC, et al
    Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic.
    Oral Oncol. 2020;107:104734.
    PubMed    


  713. PIETROBON G, Tagliabue M, Chu F, De Berardinis R, et al
    COVID alias challenge to onco-rehabilitation and to viable indications and decisions: Cues from an Italian COVID+ oral cancer patient.
    Oral Oncol. 2020 Apr 24:104745. doi: 10.1016/j.oraloncology.2020.104745.
    PubMed    


  714. CARSUZAA F, Gorphe P, Vergez S, Malard O, et al
    Consensus on resectability in N3 head and neck squamous cell carcinomas: GETTEC recommendations.
    Oral Oncol. 2020;106:104733.
    PubMed     Abstract available


  715. YUEN E, Fote G, Horwich P, Nguyen SA, et al
    Head and neck cancer care in the COVID-19 pandemic: A brief update.
    Oral Oncol. 2020 Apr 23:104738. doi: 10.1016/j.oraloncology.2020.104738.
    PubMed    


  716. JAYARAJ R, Shetty S, Kumaraswamy C, Raymond G, et al
    Clinical validity of clinicopathological and prognostic significance of circulating tumor cells in head and neck squamous cell carcinoma.
    Oral Oncol. 2020 Apr 21:104727. doi: 10.1016/j.oraloncology.2020.104727.
    PubMed    


  717. QIN G, Rai R, Zhang R, Su Y, et al
    Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Oral Oncol. 2020;106:104704.
    PubMed     Abstract available


  718. KUMAR N, Deo SVS, Mishra D
    Distant recurrence of oral carcinoma at tracheostomy site: A rare presentation.
    Oral Oncol. 2020 Apr 20:104692. doi: 10.1016/j.oraloncology.2020.104692.
    PubMed    


  719. LI B, Ren M, Zhou X, Han Q, et al
    Targeting tumor-associated macrophages in head and neck squamous cell carcinoma.
    Oral Oncol. 2020;106:104723.
    PubMed     Abstract available


  720. NAGAO T, Warnakulasuriya S
    Screening for oral cancer: Future prospects, research and policy development for Asia.
    Oral Oncol. 2020;105:104632.
    PubMed     Abstract available


  721. FERNANDES DT, Prado-Ribeiro AC, Markman RL, Morais K, et al
    The impact of an educational video about radiotherapy and its toxicities in head and neck cancer patients. Evaluation of patients' understanding, anxiety, depression, and quality of life.
    Oral Oncol. 2020;106:104712.
    PubMed     Abstract available


  722. DA CRUZ PEREZ DE, Passos KKM, Machado RA, Martelli-Junior H, et al
    Continuing education in oral cancer during coronavirus disease 2019 (covid-19) outbreak.
    Oral Oncol. 2020 Apr 16:104713. doi: 10.1016/j.oraloncology.2020.104713.
    PubMed    


  723. SUN XS, Liang YJ, Jia GD, Liu SL, et al
    Establishment of a prognostic nomogram to identify optimal candidates for local treatment among patients with local recurrent nasopharyngeal carcinoma.
    Oral Oncol. 2020;106:104711.
    PubMed     Abstract available


  724. TANG SQ, Xu C, Wang XS, Tang LL, et al
    Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis.
    Oral Oncol. 2020;105:104686.
    PubMed     Abstract available


  725. MOLONY P, Werner R, Martin C, Callanan D, et al
    The role of tumour morphology in assigning HPV status in oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2020;105:104670.
    PubMed     Abstract available


  726. DHAR H, Vaish R, D'Cruz AK, Vaish R, et al
    Management of locally advanced oral cancers.
    Oral Oncol. 2020;105:104662.
    PubMed     Abstract available


  727. SALARI A, Shirkhoda M
    COVID-19 pandemic & head and neck cancer patients management: The role of virtual multidisciplinary team meetings.
    Oral Oncol. 2020 Apr 8:104693. doi: 10.1016/j.oraloncology.2020.104693.
    PubMed    


  728. KUMAR N, Bhoriwal S, Mishra D, Deo SVS, et al
    Cutaneous ulceration: A sign of methotrexate toxicity in oral cancer patient.
    Oral Oncol. 2020 Apr 6:104671. doi: 10.1016/j.oraloncology.2020.104671.
    PubMed    


  729. OLIVA M, Huang SH, Taylor R, Su J, et al
    Impact of cumulative cisplatin dose and adjuvant chemotherapy in locally-advanced nasopharyngeal carcinoma treated with definitive chemoradiotherapy.
    Oral Oncol. 2020;105:104666.
    PubMed     Abstract available


  730. KACEW AJ, Harris EJ, Lorch JH, Schoenfeld JD, et al
    Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck.
    Oral Oncol. 2020;105:104676.
    PubMed     Abstract available


  731. SHI L, Li C, Liu W
    Reply to "Is no biopsy appropriate for oral potentially malignant lesion(s) without loss of autofluorescence using VELscope?"
    Oral Oncol. 2020;103:104566.
    PubMed    


  732. PATEL RR, Ludmir EB, Augustyn A, Zaorsky NG, et al
    De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials.
    Oral Oncol. 2020;103:104608.
    PubMed     Abstract available


  733. WOOD CB, Rohde SL, Sinard RJ, Mannion K, et al
    Incidence of pedicle ossification in osseous free flap reconstruction in the head and neck.
    Oral Oncol. 2020;103:104611.
    PubMed     Abstract available


  734. CORDESMEYER R, Laskawi R, Schliephake H, Kauffmann P, et al
    Shallow whole genome sequencing of adenoid cystic carcinomas of the salivary glands identifies specific chromosomal aberrations related to tumor progression.
    Oral Oncol. 2020;103:104615.
    PubMed     Abstract available


  735. NASSER A, Purgina B, Laurie S
    Paraneoplastic manifestations of salivary gland tumours: A case report and review.
    Oral Oncol. 2020;103:104582.
    PubMed     Abstract available


  736. DE VIRGILIO A, Costantino A, Mercante G, Di Maio P, et al
    Trans-oral robotic surgery in the management of parapharyngeal space tumors: A systematic review.
    Oral Oncol. 2020;103:104581.
    PubMed     Abstract available


  737. CANAVAN JF, Harr BA, Bodmann JW, Reddy CA, et al
    Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer.
    Oral Oncol. 2020;103:104585.
    PubMed     Abstract available


  738. LUKACH L, Lehman H, Livoff A, Nahlieli O, et al
    Mantle cell lymphoma of the oral cavity: An uncommon site for an uncommon lesion, two new cases and literature review.
    Oral Oncol. 2020;103:104578.
    PubMed    


  739. LOMBARDI N, Varoni E, Sardella A, Lodi G, et al
    Oral Kaposi's sarcoma in a HIV-negative young patient.
    Oral Oncol. 2020;103:104567.
    PubMed    


  740. ZOTTI F, Fior A, Lonardi F, Albanese M, et al
    Oral MALT Lymphoma: Something to remember.
    Oral Oncol. 2020;103:104564.
    PubMed     Abstract available


  741. ANAND R, Pandiar D, Kamboj M
    Financial burden of oral squamous cell carcinoma in India.
    Oral Oncol. 2020;103:104528.
    PubMed    


  742. CABEZAS-CAMARERO S, Perez-Alfayate R, Puebla F, Cabrera-Martin MN, et al
    Increased clinical and plasma EBV DNA responses to platinum-gemcitabine after nivolumab in patients with heavily platinum-pretreated nasopharyngeal cancer.
    Oral Oncol. 2020;103:104527.
    PubMed    


  743. AGGARWAL K, Thakur S, Rao V, Shetty SS, et al
    Radiation induced hypothyroidism - Why is early intervention necessary?
    Oral Oncol. 2020;103:104444.
    PubMed    


    March 2020
  744. OH LJ, Phan K, Kim SW, Low TH, et al
    Elective neck dissection versus observation for early-stage oral squamous cell carcinoma: Systematic review and meta-analysis.
    Oral Oncol. 2020;105:104661.
    PubMed     Abstract available


  745. MAZUL AL, Colditz GA, Zevallos JP
    Factors associated with HPV testing in oropharyngeal cancer in the National Cancer Data Base from 2013 to 2015.
    Oral Oncol. 2020;104:104609.
    PubMed     Abstract available


  746. SCIUBBA J, Epstein J
    Is no biopsy appropriate for oral potentially malignant lesion(s) without loss of autofluorescence using VELscope(R)? A large prospective diagnostic study.
    Oral Oncol. 2020;102:104474.
    PubMed    


  747. DAUZIER E, Lacas B, Blanchard P, Auperin A, et al
    Response to R. Jayaraj.
    Oral Oncol. 2020;102:104439.
    PubMed    


  748. OGI K, Kobayashi J, Nakagaki T, Okamoto J, et al
    Chemotherapy after progression on nivolumab is essential for responders with genetic alterations of driver gene: Review of two recurrent/metastatic oral squamous cell carcinoma patients.
    Oral Oncol. 2020;102:104509.
    PubMed    


  749. SANDULACHE VC, Lei YL, Heasley LE, Chang M, et al
    Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.
    Oral Oncol. 2020;102:104440.
    PubMed    


    February 2020
  750. YIN X, Shan C, Wang J, Zhang H, et al
    Factors associated with the quality of life for hospitalized patients with HPV-associated oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2020;103:104590.
    PubMed     Abstract available


  751. JAYARAJ R, Kumarasamy C, Sabarimurugan S, Madhav MR, et al
    Conceptual interpretation of findings on systematic review and meta-analysis of altered-fractionation radiotherapy improves local control in the early-stage glottic carcinoma.
    Oral Oncol. 2020;101:104319.
    PubMed    


  752. LU L, Gaffney SG, Cannataro VL, Townsend J, et al
    Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma.
    Oral Oncol. 2020;101:104554.
    PubMed     Abstract available


  753. FAKHRY C, Waterboer T, Westra WH, Rooper LM, et al
    Distinct biomarker and behavioral profiles of human papillomavirus-related oropharynx cancer patients by age.
    Oral Oncol. 2020;101:104522.
    PubMed     Abstract available


  754. WANG Z, Qu Y, Wang K, Wu R, et al
    The value of preoperative radiotherapy in the treatment of locally advanced nasal cavity and paranasal sinus squamous cell carcinoma: A single institutional experience.
    Oral Oncol. 2020;101:104512.
    PubMed     Abstract available


  755. SEIM NB, Old M, Petrisor D, Thomas W, et al
    Head and neck free flap survival when requiring interposition vein grafting: A multi-instiutional review.
    Oral Oncol. 2020;101:104482.
    PubMed     Abstract available


  756. CHARGI N, Bril SI, Swartz JE, Wegner I, et al
    Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2020;101:104519.
    PubMed     Abstract available


  757. SZTURZ P, Vermorken JB
    Management of recurrent and metastatic oral cavity cancer: Raising the bar a step higher.
    Oral Oncol. 2020;101:104492.
    PubMed     Abstract available


  758. DAVIES A, Waylen A, Leary S, Thomas S, et al
    Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
    Oral Oncol. 2020;101:104504.
    PubMed     Abstract available


  759. SHETTY SS, Kudpaje A, Rao V
    Incidental finding of tongue cancer in a PET scan: A fusion of anatomic and metabolic imaging.
    Oral Oncol. 2020;101:104374.
    PubMed    


  760. SATO K, Ono T, Sato F, Kawahara A, et al
    Different responses to nivolumab therapy between primary and metastatic tumors in a patient with recurrent hypopharyngeal squamous cell carcinoma.
    Oral Oncol. 2020;101:104366.
    PubMed     Abstract available


    January 2020
  761. VAISH R, Shah S, Chaukar D
    Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic cancer.
    Oral Oncol. 2020;100:104511.
    PubMed    


  762. CHATFIELD-REED K, Gui S, O'Neill WQ, Teknos TN, et al
    HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.
    Oral Oncol. 2020;100:104488.
    PubMed     Abstract available


  763. CHEN C, Lohavanichbutr P, Zhang Y, Houck JR, et al
    Prediction of survival of HPV16-negative, p16-negative oral cavity cancer patients using a 13-gene signature: A multicenter study using FFPE samples.
    Oral Oncol. 2020;100:104487.
    PubMed     Abstract available


  764. KANSARA S, Bell D, Weber R
    Surgical management of non melanoma skin cancer of the head and neck.
    Oral Oncol. 2020;100:104485.
    PubMed     Abstract available


  765. MAZZOLA F, Smithers F, Cheng K, Mukherjee P, et al
    Time and cost-analysis of virtual surgical planning for head and neck reconstruction: A matched pair analysis.
    Oral Oncol. 2020;100:104491.
    PubMed     Abstract available


  766. NI Y, Zhang X, Zhang Z, Liang W, et al
    Assessment of fibula flap with flexor hallucis longus's effect on head & neck tumor patients' quality of life and function of donor site.
    Oral Oncol. 2020;100:104489.
    PubMed     Abstract available


  767. THIAGARAJAN S, Dhar H, Bhattacharjee A, Fatehi KS, et al
    Patterns of failure and outcomes in cT4 Oral squamous cell carcinoma (OSCC) undergoing upfront surgery in comparison to Neo-Adjuvant Chemotherapy (NACT) followed by surgery: A Matched Pair analysis.
    Oral Oncol. 2020;100:104455.
    PubMed    


  768. MANTSOPOULOS K, Iro H, Constantinidis J
    Complex midfacial defects: Is the extended Abbe flap the ideal solution to a tough problem?
    Oral Oncol. 2020;100:104470.
    PubMed     Abstract available


  769. BHATLAWANDE H, Desai KM, Kale AD, Angadi P, et al
    Co-occurrence of Warthin's tumor with oral squamous cell carcinoma - Overlapping risk factors and implications.
    Oral Oncol. 2020;100:104449.
    PubMed    


  770. SHAH AK, Patil SB
    Second field tumors in oral submucous fibrosis: An abandoned phenomenon?
    Oral Oncol. 2020;100:104452.
    PubMed    


    December 2019
  771. YOUNG RJ, Bressel M, Porceddu S, Cernelc J, et al
    Validation and characterisation of prognostically significant PD-L1(+) immune cells in HPV+ oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2019;101:104516.
    PubMed     Abstract available


    November 2019
  772. LU DJ, Luu M, Nguyen AT, Scher KS, et al
    Survival outcomes with concomitant chemoradiotherapy in older adults with oropharyngeal carcinoma in an era of increasing human papillomavirus (HPV) prevalence.
    Oral Oncol. 2019;99:104472.
    PubMed     Abstract available


  773. THIAGARAJAN S, Nair SV
    Prognostic determinants of locally advanced buccal mucosa cancer: Do we need to relook the current staging criteria? - Needs to be interpreted carefully.
    Oral Oncol. 2019;98:158-159.
    PubMed    


    October 2019
  774. MICCIO JA, Verma V, Kelly J, Kann BH, et al
    Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition.
    Oral Oncol. 2019;99:104447.
    PubMed     Abstract available


    September 2019
  775. SANFORD NN, Hwang WL, Pike LRG, Lam AC, et al
    Trimodality therapy for HPV-positive oropharyngeal cancer: A population-based study: Trimodality therapy for HPV+OPC.
    Oral Oncol. 2019;98:28-34.
    PubMed     Abstract available


  776. GRONHOJ C, Kronberg Jakobsen K, Kjaer E, Friborg J, et al
    Comorbidity in HPV+ and HPV- oropharyngeal cancer patients: A population-based, case-control study.
    Oral Oncol. 2019;96:1-6.
    PubMed     Abstract available


    August 2019
  777. IGANEJ S, Beard BW, Chen J, Buchschacher GL Jr, et al
    Triweekly carboplatin as a potential de-intensification agent in concurrent chemoradiation for early-stage HPV-associated oropharyngeal cancer.
    Oral Oncol. 2019;97:18-22.
    PubMed     Abstract available


  778. BHATTASALI O, Ryoo JJ, Thompson LDR, Abdalla IA, et al
    Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
    Oral Oncol. 2019;95:74-78.
    PubMed     Abstract available


  779. MISIUKIEWICZ K, Gupta V, Miles BA, Bakst R, et al
    Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trial.
    Oral Oncol. 2019;95:170-177.
    PubMed     Abstract available


  780. HANNA GJ, Lau CJ, Mahmood U, Supplee JG, et al
    Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.
    Oral Oncol. 2019;95:120-126.
    PubMed     Abstract available


    July 2019
  781. JAYARAJ R, Kumarasamy C, Madhav MR, Shetty S, et al
    Clinical validation of the Salivary HPV DNA assessment and its link to the locoregional disease burden in advanced HPV associated oropharyngeal cancer.
    Oral Oncol. 2019 Jul 30. pii: S1368-8375(19)30264.
    PubMed    


    June 2019
  782. IQBAL MS, Kovarik J, Kelly C
    Limiting radiotherapy field to ipsilateral side only in unresected lateralised HPV positive N2b squamous cell carcinoma of the tonsil.
    Oral Oncol. 2019 Jun 12. pii: S1368-8375(19)30203.
    PubMed    


    May 2019
  783. MARTIN-GOMEZ L, Fulp WJ, Schell MJ, Sirak B, et al
    Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases.
    Oral Oncol. 2019;92:85-91.
    PubMed     Abstract available


  784. BURR AR, Harari PM, Ko HC, Bruce JY, et al
    Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer.
    Oral Oncol. 2019;92:52-56.
    PubMed     Abstract available


    February 2019
  785. MALTHIERY E, De Boutray M, Koren C, Albouy JP, et al
    Squamous cell carcinoma around a dental implant: A case report and literature review.
    Oral Oncol. 2019 Feb 21. pii: S1368-8375(19)30041.
    PubMed    


    January 2019
  786. PAOLINI F, Bonomo C, Terrenato I, Pennetti A, et al
    Beta human papillomaviruses in middle ear squamous cell carcinoma.
    Oral Oncol. 2019 Jan 18. pii: S1368-8375(19)30004.
    PubMed    


  787. LIU HY, Milne R, Lock G, Panizza BJ, et al
    Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
    Oral Oncol. 2019;88:153-159.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: